+Follow
LST3
No personal profile
706
Follow
58
Followers
0
Topic
0
Badge
Posts
Hot
LST3
2022-08-16
Ok
US STOCKS-Wall Street Climbs, Adding to Recent Gains As Megacaps Rise
LST3
2021-07-16
Nice
Sorry, the original content has been removed
LST3
2021-07-10
Good
Sorry, the original content has been removed
LST3
2021-06-17
Good
Sorry, the original content has been removed
LST3
2021-08-02
Yes
Sorry, the original content has been removed
LST3
2021-07-19
Ok
Sorry, the original content has been removed
LST3
2021-08-01
Ok
Sorry, the original content has been removed
LST3
2021-07-26
Ok
Sorry, the original content has been removed
LST3
2021-07-05
Nice
Sorry, the original content has been removed
LST3
2022-06-26
Ok
Sorry, the original content has been removed
LST3
2021-06-27
Buy
Sorry, the original content has been removed
LST3
2021-07-27
Good
Sorry, the original content has been removed
LST3
2021-07-20
Nice
Sorry, the original content has been removed
LST3
2021-07-20
Buy
Sorry, the original content has been removed
LST3
2021-02-21
Good
Sorry, the original content has been removed
LST3
2022-10-12
Ok
Amazon to Shut Down "Explore" Virtual Tour Product in Latest Cut
LST3
2021-09-23
Good
Nike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate
LST3
2021-09-17
Good
3 Top Warren Buffett Stocks to Buy and Hold
Go to Tiger App to see more news
Invest in Global Markets with Tiger Brokers!
Open App
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3576578158811365","uuid":"3576578158811365","gmtCreate":1613564872405,"gmtModify":1617071065105,"name":"LST3","pinyin":"lst3","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":58,"headSize":706,"tweetSize":99,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.16","exceedPercentage":"93.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9980010210,"gmtCreate":1665616729331,"gmtModify":1676537635029,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9980010210","repostId":"2275695842","repostType":4,"repost":{"id":"2275695842","kind":"highlight","pubTimestamp":1665615903,"share":"https://ttm.financial/m/news/2275695842?lang=&edition=full_marsco","pubTime":"2022-10-13 07:05","market":"us","language":"en","title":"Amazon to Shut Down \"Explore\" Virtual Tour Product in Latest Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2275695842","media":"Bloomberg","summary":"Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched ","content":"<html><head></head><body><p>Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched during the pandemic, in the latest belt-tightening move by the online giant as it adjusts to slowing sales.</p><p>“At Amazon, we are always experimenting and testing ideas like Amazon Explore,” the company said Wednesday in a statement. “While we are winding down this program, we’ll continue innovating and investing in new ways to delight our customers. We are supporting our affected employees during this transition and working to identify other opportunities within Amazon.”</p><p>Amazon launched Explore in 2020, targeting those suffering cabin fever during pandemic lockdowns. Users could pay $7.50 for a 50-minute guided tour of sites such as an animal sanctuary in Costa Rica or $50 for an hourlong virtual stroll through the markets of Venice.</p><p>Amazon has been trimming experimental programs to reduce costs. Among the features or products that have been curtailed or canceled are Scout, an autonomous delivery robot and Amazon Glow, a kids-focused video calling device. The company has also frozen hiring for its corporate retail teams and is winding down Amazon Care, its startup telehealth service.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Amazon to Shut Down \"Explore\" Virtual Tour Product in Latest Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon to Shut Down \"Explore\" Virtual Tour Product in Latest Cut\n</h2>\n<h4 class=\"meta\">\n\n\n2022-10-13 07:05 GMT+8 <a href=\"https://www.bloomberg.com/news/articles/2022-10-12/amazon-to-shutter-virtual-tour-product-explore-in-latest-cut?srnd=technology-vp\"><strong>Bloomberg</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched during the pandemic, in the latest belt-tightening move by the online giant as it adjusts to slowing...</p>\n<a href=\"https://www.bloomberg.com/news/articles/2022-10-12/amazon-to-shutter-virtual-tour-product-explore-in-latest-cut?srnd=technology-vp\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.bloomberg.com/news/articles/2022-10-12/amazon-to-shutter-virtual-tour-product-explore-in-latest-cut?srnd=technology-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2275695842","content_text":"Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched during the pandemic, in the latest belt-tightening move by the online giant as it adjusts to slowing sales.“At Amazon, we are always experimenting and testing ideas like Amazon Explore,” the company said Wednesday in a statement. “While we are winding down this program, we’ll continue innovating and investing in new ways to delight our customers. We are supporting our affected employees during this transition and working to identify other opportunities within Amazon.”Amazon launched Explore in 2020, targeting those suffering cabin fever during pandemic lockdowns. Users could pay $7.50 for a 50-minute guided tour of sites such as an animal sanctuary in Costa Rica or $50 for an hourlong virtual stroll through the markets of Venice.Amazon has been trimming experimental programs to reduce costs. Among the features or products that have been curtailed or canceled are Scout, an autonomous delivery robot and Amazon Glow, a kids-focused video calling device. The company has also frozen hiring for its corporate retail teams and is winding down Amazon Care, its startup telehealth service.","news_type":1},"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9910825806,"gmtCreate":1663598757506,"gmtModify":1676537298819,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9910825806","repostId":"1117965285","repostType":4,"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9993049644,"gmtCreate":1660609376590,"gmtModify":1676536363679,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9993049644","repostId":"2259122027","repostType":4,"isVote":1,"tweetType":1,"viewCount":1088,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9046088881,"gmtCreate":1656284550043,"gmtModify":1676535796618,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046088881","repostId":"1184080362","repostType":2,"repost":{"id":"1184080362","kind":"news","pubTimestamp":1656283742,"share":"https://ttm.financial/m/news/1184080362?lang=&edition=full_marsco","pubTime":"2022-06-27 06:49","market":"us","language":"en","title":"Stocks Pace Towards Worst Start since 1970: What to Know This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1184080362","media":"Yahoo Finance","summary":"The week ahead will bring to an end the second quarter and the first half of what has been a challen","content":"<html><head></head><body><p>The week ahead will bring to an end the second quarter and the first half of what has been a challenging 2022 for investors.</p><p>Several key economic reports, including core PCE inflation – the Federal Reserve's preferred measure of consumer prices – are on tap, along with earnings from Nike (NKE), Jefferies (JEF), Micron Technology (MU), and Bed Bath & Beyond (BBBY).</p><p>The S&P 500 rose by more than 3% on Friday and gained over 6% for the week, its second-best week this year and its first weekly rise since late May.</p><p>The benchmark index still remains on pace for one its worst opening six months since 1970. Only five times since 1932 has the S&P 500 lost 15% or more in the first six months of a year; through Friday's close, the benchmark index was down just under 18%.</p><p>“As bad as [this year] has been for investors, the good news is previous years that were down at least 15% at the midway point to the year saw the final six months higher every single time, with an average return of nearly 24%,” LPL Financial chief market strategist Ryan Detrick noted earlier this week.</p><p>And indeed, investors remain generally optimistic that a rebound is ahead despite this year’s downturn.</p><p>Although analysts have lowered their price targets on S&P 500 companies in recent months — bringing the consensus bottom-up target price for the index below 5,000 for the first time since August 2021 — the estimate of 4,987.28 as of June 23 remains 31.4% above the closing price of the same day’s closing price of 3,795.73,according to data from FactSet.</p><p>This suggests analysts expect the index to rise by more than 30% in the next 12 months.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/ec36198085b4a3361002d2db9a792adf\" tg-height=\"556\" tg-width=\"960\" width=\"100%\"/><span>The S&P 500 bottom-up target price. vs. closing price over the past 12 months.</span></p><p>J.P. Morgan strategist Marko Kolanovic indicated in a note to clients Friday that U.S. equities may climb as much as 7% next week as investors rebalance portfolios amid the end of the month, second quarter, and first half of the year.</p><p>“Next week’s rebalance is important since equity markets were down significantly over the past month, quarter and six-month time period,” Kolanovic said. \"On top of that, the market is in an oversold condition, cash balances are at record levels, and recent market shorting activity reached levels not seen since 2008.\"</p><p>On the economic calendar, personal consumption expenditures (PCE) data will be closely watched by traders this week. The Bureau of Economic Analysis will release its monthly PCE deflator on Thursday, giving investors the latest view on inflation across the U.S. economy as the Federal Reserve moves up its key benchmark interest rate to tame price increases.</p><p>Economists surveyed by Bloomberg expect PCE to rise 0.7% in May compared to 0.2% the prior month. On a year-over-year basis, the PCE deflator is expected to accelerate 6.4%, up from a climb of 6.3% in April.</p><p>The core PCE index, which strips out the cost of food and energy, is expected to hold steady from the prior month’s print. Economists are looking for a 5.1% increase in core PCE in May, compared to April’s 5.1% rise.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/0a3c816f919804bca939b29921c02462\" tg-height=\"644\" tg-width=\"960\" width=\"100%\"/><span>U.S. Federal Reserve Board Chair Jerome Powell testifies before a House Financial Services Committee hearing in Washington, U.S., June 23, 2022. REUTERS/Mary F. Calvert</span></p><p>The latest PCE data will come as the U.S. central bank’s fight against inflation looks increasingly more complex, with a growing number of economists and strategists on Wall Street suggesting that the Fed will not be able to rein in prices without tipping the economy into a recession.</p><p>“I do worry that the probability of a soft landing, which means you bring down inflation without unduly hurting growth and employment, has declined significantly because of a series of Federal Reserve mistakes,” economist Mohamed El-Erian told Yahoo Finance Live last week.</p><p>Elsewhere on the economic calendar, investors will keep a close eye on durable goods figures on Monday, the Conference Board’s consumer confidence reading out Tuesday, and several reports on manufacturing and housing throughout the week. Investors will also get a third and final read on first quarter GDP.</p><p>On the earnings side, reports from Nike (NKE), Bed Bath & Beyond (BBBY), Jefferies (JEF), and Micron Technology (MU) will feature.</p><p>—</p><p><b>Economic calendar</b></p><p><b>Monday:</b><b><i>Durable Goods Orders</i></b>, May preliminary (0.2% expected, 0.5% during prior month); <b><i>Durables Excluding Transportation</i></b>, May preliminary (0.3% expected, 0.4% during prior month); <b><i>Pending Home Sales</i></b>, month-over-month, May (-3.9% expected, -3.9% during prior month);<b><i>Pending Home Sales NSA</i></b>, year-over-year, April (-11.5% during prior month); <b><i>Dallas Fed Manufacturing Activity</i></b>, June (-6.5 expected, -7.3 during prior month)</p><p><b>Tuesday:</b><b><i>Advance Goods Trade Balance</i></b>, May (-$105.4 billion expected, -$105.9 billion during prior month, revised to -$106.7 billion); <b><i>Wholesale Inventories</i></b>, month-over-month, May preliminary (2.2% expected, 2.2% during previous month); <b><i>Retail Inventories</i></b>, month-over-month, May (1.6 expected, 0.7% during prior month); <b><i>FHFA Housing Pricing Index</i></b>, April (1.6% expected, 1.5% during prior month); <b><i>S&P CoreLogic Case-Shiller 20-City Composite</i></b>, month-over-month, April (1.85% expected, 2.42% during prior month); <b><i>S&P CoreLogic Case-Shiller 20-City Composite</i></b>, year-over-year, April (21.20% expected, 21.17% during prior month); <b><i>S&P CoreLogic Case-Shiller U.S. National Home Price Index</i></b>, year-over-year, April (20.55% during prior month); <b><i>Conference Board Consumer Confidence</i></b>, June (100 expected, 106.4 during prior month); <b><i>Richmond Fed Manufacturing Index</i></b>, June (-5 expected, -9 during prior month)</p><p><b>Wednesday:</b><b><i>MBA Mortgage Applications</i></b>, week ended June 24 (-4.2% during prior week); <b><i>GDP Annualized</i></b>, quarter-over-quarter, 1Q third (-1.5% expected, -1.5% prior); <b><i>Personal Consumption</i></b>, quarter-over-quarter, 1Q third (3.1% expected, 3.1% prior); <b><i>GDP Price Index</i></b>, quarter-over-quarter, 1Q third (8.1% expected, 8.1% prior); <b><i>Core PCE</i></b>, quarter-over-quarter, 1Q second (5.1% expected, 5.1% prior)</p><p><b>Thursday:</b><b><i>Personal Income</i></b>, month-over-month, May (0.5% expected, 0.4% during prior month); <b><i>Personal Spending</i></b>, month-over-month, May (0.4% expected, 0.9% during prior month); <b><i>Real Personal Spending</i></b>, month-over-month, May (-0.2% expected, 0.7% during prior month);<b><i>Initial Jobless Claims</i></b>, week ended June 25 (230,000 expected, 229,000 during prior week); <b><i>Continuing Claims</i></b>, week ended June 18 (1.310 million expected, 1.315 million during prior week);<b><i>PCE Deflator</i></b>, month-over-month, May (0.7% expected, 0.2% during prior month); <b><i>PCE Deflator</i></b>, year-over-year, May (6.4% expected, 6.3% during prior month); <b><i>PCE Core Deflator</i></b>, month-over-month, May (0.4% expected, 0.3% during prior month); <b><i>PCE Core Deflator</i></b>, year-over-year, May (4.8% expected, 4.9% during prior month); <b><i>MNI Chicago PMI</i></b>, June (58 expected, 60.3 during prior month)</p><p><b>Friday:</b><b><i>S&P Global U.S. Manufacturing PMI</i></b>, June final (52.4 expected, 52.4 prior); <b><i>Construction Spending</i></b>, month-over-month, May (0.4% expected, 0.2% during prior month); <b><i>ISM Manufacturing</i></b>, June (54.7 expected, 56.1 during prior month); <b><i>ISM Prices Paid</i></b>, June (80.0 expected, 82.2 during prior month), ISM New Orders, June (55.1 during prior month); <b><i>ISM Employment,</i></b>June (49.6 during prior month); <b><i>Wards Total Vehicle Sales</i></b>, June (13.40 million, 12.68 during prior month)</p><p>—</p><p><b>Earnings calendar</b></p><p><b>Monday</b></p><p>Before market open:<i>No notable reports scheduled for release.</i></p><p>After market close:<b>Nike</b>(NKE), <b>Jefferies Financial Group</b>(JEF), <b>Trip.com Group</b>(TCOM)</p><p><b>Tuesday</b></p><p>Before market open:<i>No notable reports scheduled for release.</i></p><p>After market close: <b>AeroVironment</b>(AVAV)</p><p><b>Wednesday</b></p><p>Before market open: <b>Barnes & Noble Education</b>(BNED), <b>Bed Bath & Beyond</b>(BBBY), <b>General Mills</b>(GIS), <b>McCormick & Co.</b>(MKC), <b>Paychex</b>(PAYX)</p><p>After market close: <b>MillerKnoll</b>(MLKN)</p><p><b>Thursday</b></p><p>Before market open: <b>Constellation Brands</b>(STZ)</p><p>After market close: <b>Micron Technology</b>(MU), <b>Walgreens Boots Alliance</b>(WBA)</p><p><b>Friday</b></p><p><i>No notable reports scheduled for release.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stocks Pace Towards Worst Start since 1970: What to Know This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks Pace Towards Worst Start since 1970: What to Know This Week\n</h2>\n<h4 class=\"meta\">\n\n\n2022-06-27 06:49 GMT+8 <a href=\"https://finance.yahoo.com/news/what-to-know-this-week-in-markets-june-27-184417186.html\"><strong>Yahoo Finance</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>The week ahead will bring to an end the second quarter and the first half of what has been a challenging 2022 for investors.Several key economic reports, including core PCE inflation – the Federal ...</p>\n<a href=\"https://finance.yahoo.com/news/what-to-know-this-week-in-markets-june-27-184417186.html\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/what-to-know-this-week-in-markets-june-27-184417186.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184080362","content_text":"The week ahead will bring to an end the second quarter and the first half of what has been a challenging 2022 for investors.Several key economic reports, including core PCE inflation – the Federal Reserve's preferred measure of consumer prices – are on tap, along with earnings from Nike (NKE), Jefferies (JEF), Micron Technology (MU), and Bed Bath & Beyond (BBBY).The S&P 500 rose by more than 3% on Friday and gained over 6% for the week, its second-best week this year and its first weekly rise since late May.The benchmark index still remains on pace for one its worst opening six months since 1970. Only five times since 1932 has the S&P 500 lost 15% or more in the first six months of a year; through Friday's close, the benchmark index was down just under 18%.“As bad as [this year] has been for investors, the good news is previous years that were down at least 15% at the midway point to the year saw the final six months higher every single time, with an average return of nearly 24%,” LPL Financial chief market strategist Ryan Detrick noted earlier this week.And indeed, investors remain generally optimistic that a rebound is ahead despite this year’s downturn.Although analysts have lowered their price targets on S&P 500 companies in recent months — bringing the consensus bottom-up target price for the index below 5,000 for the first time since August 2021 — the estimate of 4,987.28 as of June 23 remains 31.4% above the closing price of the same day’s closing price of 3,795.73,according to data from FactSet.This suggests analysts expect the index to rise by more than 30% in the next 12 months.The S&P 500 bottom-up target price. vs. closing price over the past 12 months.J.P. Morgan strategist Marko Kolanovic indicated in a note to clients Friday that U.S. equities may climb as much as 7% next week as investors rebalance portfolios amid the end of the month, second quarter, and first half of the year.“Next week’s rebalance is important since equity markets were down significantly over the past month, quarter and six-month time period,” Kolanovic said. \"On top of that, the market is in an oversold condition, cash balances are at record levels, and recent market shorting activity reached levels not seen since 2008.\"On the economic calendar, personal consumption expenditures (PCE) data will be closely watched by traders this week. The Bureau of Economic Analysis will release its monthly PCE deflator on Thursday, giving investors the latest view on inflation across the U.S. economy as the Federal Reserve moves up its key benchmark interest rate to tame price increases.Economists surveyed by Bloomberg expect PCE to rise 0.7% in May compared to 0.2% the prior month. On a year-over-year basis, the PCE deflator is expected to accelerate 6.4%, up from a climb of 6.3% in April.The core PCE index, which strips out the cost of food and energy, is expected to hold steady from the prior month’s print. Economists are looking for a 5.1% increase in core PCE in May, compared to April’s 5.1% rise.U.S. Federal Reserve Board Chair Jerome Powell testifies before a House Financial Services Committee hearing in Washington, U.S., June 23, 2022. REUTERS/Mary F. CalvertThe latest PCE data will come as the U.S. central bank’s fight against inflation looks increasingly more complex, with a growing number of economists and strategists on Wall Street suggesting that the Fed will not be able to rein in prices without tipping the economy into a recession.“I do worry that the probability of a soft landing, which means you bring down inflation without unduly hurting growth and employment, has declined significantly because of a series of Federal Reserve mistakes,” economist Mohamed El-Erian told Yahoo Finance Live last week.Elsewhere on the economic calendar, investors will keep a close eye on durable goods figures on Monday, the Conference Board’s consumer confidence reading out Tuesday, and several reports on manufacturing and housing throughout the week. Investors will also get a third and final read on first quarter GDP.On the earnings side, reports from Nike (NKE), Bed Bath & Beyond (BBBY), Jefferies (JEF), and Micron Technology (MU) will feature.—Economic calendarMonday:Durable Goods Orders, May preliminary (0.2% expected, 0.5% during prior month); Durables Excluding Transportation, May preliminary (0.3% expected, 0.4% during prior month); Pending Home Sales, month-over-month, May (-3.9% expected, -3.9% during prior month);Pending Home Sales NSA, year-over-year, April (-11.5% during prior month); Dallas Fed Manufacturing Activity, June (-6.5 expected, -7.3 during prior month)Tuesday:Advance Goods Trade Balance, May (-$105.4 billion expected, -$105.9 billion during prior month, revised to -$106.7 billion); Wholesale Inventories, month-over-month, May preliminary (2.2% expected, 2.2% during previous month); Retail Inventories, month-over-month, May (1.6 expected, 0.7% during prior month); FHFA Housing Pricing Index, April (1.6% expected, 1.5% during prior month); S&P CoreLogic Case-Shiller 20-City Composite, month-over-month, April (1.85% expected, 2.42% during prior month); S&P CoreLogic Case-Shiller 20-City Composite, year-over-year, April (21.20% expected, 21.17% during prior month); S&P CoreLogic Case-Shiller U.S. National Home Price Index, year-over-year, April (20.55% during prior month); Conference Board Consumer Confidence, June (100 expected, 106.4 during prior month); Richmond Fed Manufacturing Index, June (-5 expected, -9 during prior month)Wednesday:MBA Mortgage Applications, week ended June 24 (-4.2% during prior week); GDP Annualized, quarter-over-quarter, 1Q third (-1.5% expected, -1.5% prior); Personal Consumption, quarter-over-quarter, 1Q third (3.1% expected, 3.1% prior); GDP Price Index, quarter-over-quarter, 1Q third (8.1% expected, 8.1% prior); Core PCE, quarter-over-quarter, 1Q second (5.1% expected, 5.1% prior)Thursday:Personal Income, month-over-month, May (0.5% expected, 0.4% during prior month); Personal Spending, month-over-month, May (0.4% expected, 0.9% during prior month); Real Personal Spending, month-over-month, May (-0.2% expected, 0.7% during prior month);Initial Jobless Claims, week ended June 25 (230,000 expected, 229,000 during prior week); Continuing Claims, week ended June 18 (1.310 million expected, 1.315 million during prior week);PCE Deflator, month-over-month, May (0.7% expected, 0.2% during prior month); PCE Deflator, year-over-year, May (6.4% expected, 6.3% during prior month); PCE Core Deflator, month-over-month, May (0.4% expected, 0.3% during prior month); PCE Core Deflator, year-over-year, May (4.8% expected, 4.9% during prior month); MNI Chicago PMI, June (58 expected, 60.3 during prior month)Friday:S&P Global U.S. Manufacturing PMI, June final (52.4 expected, 52.4 prior); Construction Spending, month-over-month, May (0.4% expected, 0.2% during prior month); ISM Manufacturing, June (54.7 expected, 56.1 during prior month); ISM Prices Paid, June (80.0 expected, 82.2 during prior month), ISM New Orders, June (55.1 during prior month); ISM Employment,June (49.6 during prior month); Wards Total Vehicle Sales, June (13.40 million, 12.68 during prior month)—Earnings calendarMondayBefore market open:No notable reports scheduled for release.After market close:Nike(NKE), Jefferies Financial Group(JEF), Trip.com Group(TCOM)TuesdayBefore market open:No notable reports scheduled for release.After market close: AeroVironment(AVAV)WednesdayBefore market open: Barnes & Noble Education(BNED), Bed Bath & Beyond(BBBY), General Mills(GIS), McCormick & Co.(MKC), Paychex(PAYX)After market close: MillerKnoll(MLKN)ThursdayBefore market open: Constellation Brands(STZ)After market close: Micron Technology(MU), Walgreens Boots Alliance(WBA)FridayNo notable reports scheduled for release.","news_type":1},"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863702579,"gmtCreate":1632432374591,"gmtModify":1676530779311,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":" Good ","listText":" Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863702579","repostId":"2169695648","repostType":2,"repost":{"id":"2169695648","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1632428141,"share":"https://ttm.financial/m/news/2169695648?lang=&edition=full_marsco","pubTime":"2021-09-24 04:15","market":"us","language":"en","title":"Nike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2169695648","media":"Benzinga","summary":"Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period","content":"<html><body><p>Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $12.20 billion which missed the analyst consensus estimate of $12.46 billion by 2.09 percent. This is a 15.16 percent increase over sales of $10.59 billion the same period last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Nike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-24 04:15</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $12.20 billion which missed the analyst consensus estimate of $12.46 billion by 2.09 percent. This is a 15.16 percent increase over sales of $10.59 billion the same period last year.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克"},"source_url":"https://www.benzinga.com/news/earnings/21/09/23080496/nike-q1-eps-1-16-beats-1-11-estimate-sales-12-20b-miss-12-46b-estimate","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169695648","content_text":"Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $12.20 billion which missed the analyst consensus estimate of $12.46 billion by 2.09 percent. This is a 15.16 percent increase over sales of $10.59 billion the same period last year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":686,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884549153,"gmtCreate":1631922304672,"gmtModify":1676530668704,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884549153","repostId":"2168552491","repostType":4,"repost":{"id":"2168552491","kind":"highlight","pubTimestamp":1631878843,"share":"https://ttm.financial/m/news/2168552491?lang=&edition=full_marsco","pubTime":"2021-09-17 19:40","market":"us","language":"en","title":"3 Top Warren Buffett Stocks to Buy and Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2168552491","media":"Motley Fool","summary":"Invest like the legendary multibillionaire with these three great stocks.","content":"<html><body><p>Follow the leader. It's not just a game that children play. For some, it's their investment strategy.</p>\n<p>The idea is to base your own investments on a successful investor's portfolio. There are quite a few famous investors who you could follow, and Warren Buffett stands out as one of the greatest. He earned the nickname \"Oracle of Omaha\" by outperforming the market for decades.</p>\n<p>Following the leader isn't always the best investing approach, though. Your current situation and goals are likely quite different from a multibillionaire like Buffett.</p>\n<p>However, there are some stocks that the legendary investor likes that are also great long-term picks for many not-so-famous investors. Here are three top Buffett stocks to buy and hold.</p>\n<p class=\"t-img-caption\"><img height=\"auto\" src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642023%2Fwarren-buffett-tmf.jpg&w=700&op=resize\" tg-height=\"466\" tg-width=\"700\" width=\"100%\"/><span>Image source: The Motley Fool.</span></p>\n<h2>1. Berkshire Hathaway</h2>\n<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) stands out as the obvious Buffett stock to buy and hold. With Berkshire, you'll get to fully share in the great investor's future success.</p>\n<p>From 1965 (when Buffett took over) to 2020, Berkshire Hathaway stock delivered a compounded annual gain of 20%. That's nearly double the return of the <b>S&P 500 index </b>during the period. So far this year, Berkshire's performance is close to its historical average gain.</p>\n<p>Will Berkshire keep up its winning ways? Probably so. For one thing, the company sits atop a massive cash stockpile of more than $140 billion. And Berkshire's core businesses keep churning out more cash. There's a lot of dry powder to use in buying stocks at a discount in the next major pullback.</p>\n<p>Also, Buffett is allowing his investment managers to call the shots more frequently on which stocks to buy. That's resulting in a more aggressive strategy that could pay off handsomely over the long term.</p>\n<h2>2. Apple</h2>\n<p>Outside of Berkshire Hathaway itself, <b>Apple</b> (NASDAQ:AAPL) ranks as Buffett's favorite stock. It's no coincidence that Berkshire owns far more shares of the tech giant than any other company.</p>\n<p>Apple stock has given investors more than a five times return over the last five years, but shares are lagging behind the overall market in 2021. However, this $2.5 trillion company still has plenty of room to grow.</p>\n<p>The increased adoption of 5G networks continues to fuel higher iPhone sales. This trend also benefits much of Apple's ecosystem, including the App Store, iCloud, and peripheral devices such as AirPods and Apple Watch.</p>\n<p>Apple also has other growth drivers. Its AppleTV+ streaming service is becoming a powerhouse in its own right. Augmented reality and virtual reality also present tremendous growth opportunities for the company.</p>\n<h2>3. Johnson & Johnson</h2>\n<p>Buffett used to be a bigger fan of <b>Johnson & Johnson</b> (NYSE:JNJ) than he is now. The healthcare stock makes up only a tiny portion of Berkshire's portfolio. However, J&J is nonetheless one of the best Buffett stocks to own if you have a long-term investing horizon.</p>\n<p>Johnson & Johnson is the biggest global player in the fast-growing healthcare market. Many of its products are necessities instead of \"nice-to-haves.\" J&J is a leader in multiple major healthcare arenas -- consumer health, medical devices, and pharmaceuticals.</p>\n<p>Granted, Johnson & Johnson stock has badly underperformed the <b>S&P 500</b> over the last decade. The company is in a stronger position for growth now, though, thanks in large part to its research and development investments and acquisitions. Roughly one-fourth of J&J's total sales come from products launched over the past five years.</p>\n<p>Buffett lives by two rules of investing. Rule No. 1 is never lose money. Rule No. 2 is don't forget Rule No. 1. With its diversified healthcare operations and financial strength, Johnson & Johnson is arguably one of the best stocks to buy and hold to follow Buffett's investing rules.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>3 Top Warren Buffett Stocks to Buy and Hold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Warren Buffett Stocks to Buy and Hold\n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-17 19:40 GMT+8 <a href=\"https://www.fool.com/investing/2021/09/17/3-top-warren-buffett-stocks-to-buy-and-hold/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Follow the leader. It's not just a game that children play. For some, it's their investment strategy.\nThe idea is to base your own investments on a successful investor's portfolio. There are quite a ...</p>\n<a href=\"https://www.fool.com/investing/2021/09/17/3-top-warren-buffett-stocks-to-buy-and-hold/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","JNJ":"强生","AAPL":"苹果","BRK.B":"伯克希尔B"},"source_url":"https://www.fool.com/investing/2021/09/17/3-top-warren-buffett-stocks-to-buy-and-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168552491","content_text":"Follow the leader. It's not just a game that children play. For some, it's their investment strategy.\nThe idea is to base your own investments on a successful investor's portfolio. There are quite a few famous investors who you could follow, and Warren Buffett stands out as one of the greatest. He earned the nickname \"Oracle of Omaha\" by outperforming the market for decades.\nFollowing the leader isn't always the best investing approach, though. Your current situation and goals are likely quite different from a multibillionaire like Buffett.\nHowever, there are some stocks that the legendary investor likes that are also great long-term picks for many not-so-famous investors. Here are three top Buffett stocks to buy and hold.\nImage source: The Motley Fool.\n1. Berkshire Hathaway\nBerkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) stands out as the obvious Buffett stock to buy and hold. With Berkshire, you'll get to fully share in the great investor's future success.\nFrom 1965 (when Buffett took over) to 2020, Berkshire Hathaway stock delivered a compounded annual gain of 20%. That's nearly double the return of the S&P 500 index during the period. So far this year, Berkshire's performance is close to its historical average gain.\nWill Berkshire keep up its winning ways? Probably so. For one thing, the company sits atop a massive cash stockpile of more than $140 billion. And Berkshire's core businesses keep churning out more cash. There's a lot of dry powder to use in buying stocks at a discount in the next major pullback.\nAlso, Buffett is allowing his investment managers to call the shots more frequently on which stocks to buy. That's resulting in a more aggressive strategy that could pay off handsomely over the long term.\n2. Apple\nOutside of Berkshire Hathaway itself, Apple (NASDAQ:AAPL) ranks as Buffett's favorite stock. It's no coincidence that Berkshire owns far more shares of the tech giant than any other company.\nApple stock has given investors more than a five times return over the last five years, but shares are lagging behind the overall market in 2021. However, this $2.5 trillion company still has plenty of room to grow.\nThe increased adoption of 5G networks continues to fuel higher iPhone sales. This trend also benefits much of Apple's ecosystem, including the App Store, iCloud, and peripheral devices such as AirPods and Apple Watch.\nApple also has other growth drivers. Its AppleTV+ streaming service is becoming a powerhouse in its own right. Augmented reality and virtual reality also present tremendous growth opportunities for the company.\n3. Johnson & Johnson\nBuffett used to be a bigger fan of Johnson & Johnson (NYSE:JNJ) than he is now. The healthcare stock makes up only a tiny portion of Berkshire's portfolio. However, J&J is nonetheless one of the best Buffett stocks to own if you have a long-term investing horizon.\nJohnson & Johnson is the biggest global player in the fast-growing healthcare market. Many of its products are necessities instead of \"nice-to-haves.\" J&J is a leader in multiple major healthcare arenas -- consumer health, medical devices, and pharmaceuticals.\nGranted, Johnson & Johnson stock has badly underperformed the S&P 500 over the last decade. The company is in a stronger position for growth now, though, thanks in large part to its research and development investments and acquisitions. Roughly one-fourth of J&J's total sales come from products launched over the past five years.\nBuffett lives by two rules of investing. Rule No. 1 is never lose money. Rule No. 2 is don't forget Rule No. 1. With its diversified healthcare operations and financial strength, Johnson & Johnson is arguably one of the best stocks to buy and hold to follow Buffett's investing rules.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885455269,"gmtCreate":1631828023251,"gmtModify":1676530644403,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/885455269","repostId":"1138448757","repostType":4,"repost":{"id":"1138448757","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631800047,"share":"https://ttm.financial/m/news/1138448757?lang=&edition=full_marsco","pubTime":"2021-09-16 21:47","market":"us","language":"en","title":"EV maker Lucid shares jumped 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1138448757","media":"Tiger Newspress","summary":"EV maker Lucid shares jumped 4% in morning trading as its luxury sedan got 520-mile driving range ra","content":"<html><body><p>EV maker Lucid shares jumped 4% in morning trading as its luxury sedan got 520-mile driving range rating.In addition,Bank of America predicts 50% gain in Lucid, compares EV maker to Tesla and Ferrari.</p>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/8a80aaa3b21846d26be18701216b5131\" tg-height=\"470\" tg-width=\"840\"/></p>\n<p>Lucid Group Inc's Air Dream Edition Range luxury sedan has received U.S. government certification for a range of 520 miles, the electric vehicle maker said on Thursday.</p>\n<p>The sedan was the longest-range EV rated by the U.S. Environmental Protection Agency (EPA), the company said. Rival Tesla's Model S Long Range has an EPA estimated range of 405 miles.</p>\n<p>EV manufacturers are pushing to extend the driving range of their vehicles in a bid to better compete with gasoline-fueled ones. However, as consumers rapidly transition to EVs, charging infrastructure still remains a concern.</p>\n<p>The Biden administration's infrastructure bill includes $7.5 billion for electric vehicle charging stations.</p>\n<p>Lucid made its debut on the Nasdaq in July after completing its merger with a blank-check company backed by Wall Street dealmaker Michael Klein in a deal that valued the combined company at $24 billion.</p>\n<p>The EV maker in August said it would begin deliveries of fully reserved 'Air Dream Edition Range' cars later this year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>EV maker Lucid shares jumped 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV maker Lucid shares jumped 4% in morning trading\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-16 21:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>EV maker Lucid shares jumped 4% in morning trading as its luxury sedan got 520-mile driving range rating.In addition,Bank of America predicts 50% gain in Lucid, compares EV maker to Tesla and Ferrari.</p>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/8a80aaa3b21846d26be18701216b5131\" tg-height=\"470\" tg-width=\"840\"/></p>\n<p>Lucid Group Inc's Air Dream Edition Range luxury sedan has received U.S. government certification for a range of 520 miles, the electric vehicle maker said on Thursday.</p>\n<p>The sedan was the longest-range EV rated by the U.S. Environmental Protection Agency (EPA), the company said. Rival Tesla's Model S Long Range has an EPA estimated range of 405 miles.</p>\n<p>EV manufacturers are pushing to extend the driving range of their vehicles in a bid to better compete with gasoline-fueled ones. However, as consumers rapidly transition to EVs, charging infrastructure still remains a concern.</p>\n<p>The Biden administration's infrastructure bill includes $7.5 billion for electric vehicle charging stations.</p>\n<p>Lucid made its debut on the Nasdaq in July after completing its merger with a blank-check company backed by Wall Street dealmaker Michael Klein in a deal that valued the combined company at $24 billion.</p>\n<p>The EV maker in August said it would begin deliveries of fully reserved 'Air Dream Edition Range' cars later this year.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138448757","content_text":"EV maker Lucid shares jumped 4% in morning trading as its luxury sedan got 520-mile driving range rating.In addition,Bank of America predicts 50% gain in Lucid, compares EV maker to Tesla and Ferrari.\n\nLucid Group Inc's Air Dream Edition Range luxury sedan has received U.S. government certification for a range of 520 miles, the electric vehicle maker said on Thursday.\nThe sedan was the longest-range EV rated by the U.S. Environmental Protection Agency (EPA), the company said. Rival Tesla's Model S Long Range has an EPA estimated range of 405 miles.\nEV manufacturers are pushing to extend the driving range of their vehicles in a bid to better compete with gasoline-fueled ones. However, as consumers rapidly transition to EVs, charging infrastructure still remains a concern.\nThe Biden administration's infrastructure bill includes $7.5 billion for electric vehicle charging stations.\nLucid made its debut on the Nasdaq in July after completing its merger with a blank-check company backed by Wall Street dealmaker Michael Klein in a deal that valued the combined company at $24 billion.\nThe EV maker in August said it would begin deliveries of fully reserved 'Air Dream Edition Range' cars later this year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":988,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881341565,"gmtCreate":1631309059657,"gmtModify":1676530524111,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/881341565","repostId":"2166534407","repostType":4,"isVote":1,"tweetType":1,"viewCount":852,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881341901,"gmtCreate":1631308968903,"gmtModify":1676530524095,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881341901","repostId":"1158877090","repostType":4,"repost":{"id":"1158877090","kind":"news","pubTimestamp":1631259068,"share":"https://ttm.financial/m/news/1158877090?lang=&edition=full_marsco","pubTime":"2021-09-10 15:31","market":"us","language":"en","title":"Why Novavax Stock Slipped Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158877090","media":"Motley Fool","summary":"(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India a","content":"<html><body><p><i><b>(Update: Sept 10, 2021 at 04:14 a.m. ET)</b></i></p>\n<blockquote>\n<b>Authorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n<li>A report stated that the Indian government has requested additional data for Novavax's COVID-19 vaccine candidate before it can grant Emergency Use Authorization.</li>\n<li>EUA for the vaccine in India was originally expected in October but will now be pushed back.</li>\n<li>The delay isn't a huge blow for Novavax with the company's bigger opportunities in developed markets.</li>\n</ul>\n<p><b>What happened</b></p>\n<p>Shares of <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> were slipping 2.6% lower as of 3:25 p.m. EDT on Thursday. The decline came following a report by <i>The Economic Times</i> that the Indian government has requested additional data from Novavax's partner, Serum Institute of India (SII), for COVID-19 vaccine candidate NVX-CoV2373 (which is called Covovax in India).</p>\n<p><b>So what</b></p>\n<p>SII filed for Emergency Use Authorization (EUA) in India for Covovax in August. This submission was based on data from international clinical studies. An official with the country's drug regulatory agency has asked for data from a clinical trial of the vaccine conducted in India, according to<i>The Economic Times</i> article.</p>\n<p>The problem is that SII likely won't be able to submit data from the clinical studies of Covovax in India until next month. SII CEO Adar Poonawalla stated in August that his organization hoped that the COVID-19 vaccine would be launched in India in October for adults and in the first quarter of 2022 for children. That timeline will now be pushed back.</p>\n<p>This delay isn't a huge blow for Novavax, as evidenced by the relatively small drop in thevaccine stock. The company's biggest opportunities are in developed markets including the U.S. and Europe.</p>\n<p><b>Now what</b></p>\n<p>Novavax expects to file for EUA for NVX-CoV2373 in the United Kingdom within the next few weeks. That filing should be quickly followed by submissions in Australia, New Zealand, and the European Union. The company remains on track to file for U.S. EUA in the fourth quarter of 2021.</p>\n<p>Novavax fell over 2% in premarket trading.</p>\n<p><img height=\"auto\" src=\"https://static.tigerbbs.com/d6cab4a5dd8795f7fda9bc597e6d9d98\" tg-height=\"568\" tg-width=\"996\" width=\"100%\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Why Novavax Stock Slipped Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Slipped Thursday\n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-10 15:31 GMT+8 <a href=\"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.\n\nKey Points\n\nA report stated that the Indian government has ...</p>\n<a href=\"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158877090","content_text":"(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.\n\nKey Points\n\nA report stated that the Indian government has requested additional data for Novavax's COVID-19 vaccine candidate before it can grant Emergency Use Authorization.\nEUA for the vaccine in India was originally expected in October but will now be pushed back.\nThe delay isn't a huge blow for Novavax with the company's bigger opportunities in developed markets.\n\nWhat happened\nShares of Novavax were slipping 2.6% lower as of 3:25 p.m. EDT on Thursday. The decline came following a report by The Economic Times that the Indian government has requested additional data from Novavax's partner, Serum Institute of India (SII), for COVID-19 vaccine candidate NVX-CoV2373 (which is called Covovax in India).\nSo what\nSII filed for Emergency Use Authorization (EUA) in India for Covovax in August. This submission was based on data from international clinical studies. An official with the country's drug regulatory agency has asked for data from a clinical trial of the vaccine conducted in India, according toThe Economic Times article.\nThe problem is that SII likely won't be able to submit data from the clinical studies of Covovax in India until next month. SII CEO Adar Poonawalla stated in August that his organization hoped that the COVID-19 vaccine would be launched in India in October for adults and in the first quarter of 2022 for children. That timeline will now be pushed back.\nThis delay isn't a huge blow for Novavax, as evidenced by the relatively small drop in thevaccine stock. The company's biggest opportunities are in developed markets including the U.S. and Europe.\nNow what\nNovavax expects to file for EUA for NVX-CoV2373 in the United Kingdom within the next few weeks. That filing should be quickly followed by submissions in Australia, New Zealand, and the European Union. The company remains on track to file for U.S. EUA in the fourth quarter of 2021.\nNovavax fell over 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":748,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883197549,"gmtCreate":1631223252281,"gmtModify":1676530498511,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/883197549","repostId":"1176976417","repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://ttm.financial/m/news/1176976417?lang=&edition=full_marsco","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"<html><body><p>The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from <i>The Wall Street Journal</i>.</p>\n<p>The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the <i>Journal</i> report.</p>\n<p>The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.</p>\n<p>The S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech</p>\n<p>exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.</p>\n<p>Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.</p>\n<p><img height=\"auto\" src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-height=\"163\" tg-width=\"275\" width=\"100%\"/></p>\n<p>Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.</p>\n<p>According to the <i>Journal</i>, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.</p>\n<p>“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”</p>\n<p>Lilly CEO David Ricks also spoke on the call.</p>\n<p>“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.</p>\n<p>In addition to the drug-pricing plan, the <i>New York Times</i> reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.</p></body></html>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down. </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down. \n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-09 22:17 GMT+8 <a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\"><strong>Barron's</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to ...</p>\n<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883197135,"gmtCreate":1631223194427,"gmtModify":1676530498503,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/883197135","repostId":"1169339361","repostType":4,"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815524095,"gmtCreate":1630704541317,"gmtModify":1676530378934,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815524095","repostId":"2164879370","repostType":4,"repost":{"id":"2164879370","kind":"highlight","pubTimestamp":1630678680,"share":"https://ttm.financial/m/news/2164879370?lang=&edition=full_marsco","pubTime":"2021-09-03 22:18","market":"us","language":"en","title":"3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2164879370","media":"Motley Fool","summary":"These fast-paced companies should generate jaw-dropping revenue growth over the next three years.","content":"<html><body><p>Since the end of the Great Recession in 2009, growth stocks have thrived. Historically low lending rates, an ongoing quantitative easing program designed to weigh down long-term bond yields, and a free-spending Congress have all helped to make cheap capital widely abundant for businesses. This is helping to fuel acquisitions, hiring, and (most importantly) innovation.</p>\n<p>Yet for some companies, their exponential growth is just beginning. For each of the following hypergrowth stocks, Wall Street's consensus sales estimate for 2023, courtesy of <b>FactSet</b>, implies a revenue increase ranging from a low of 1,185% (yes, <i>a low of 1,185%</i>) to a high of 12,629%, compared to 2020 sales.</p>\n<h2>Moderna: Implied sales increase of 1,185%</h2>\n<p>Arguably the best-known name on this list is biotech <b>Moderna</b> (NASDAQ:MRNA). According to Wall Street, Moderna's annual revenue is expected to catapult from the $803.4 million recorded in 2020 to an estimated $10.33 billion in 2023. Interestingly, the $10.33 billion in projected sales for 2023 is about half of the $20.13 billion forecast this year.</p>\n<p>As a lot of you probably know, Modena's success is tied to the development of its coronavirus vaccine mRNA-1273. When the company ran a large-scale study of its COVID-19 vaccine, the results (released in November) demonstrated a vaccine efficacy (VE) of 94% and a strong propensity to keep vaccinated individuals from getting severe forms of the disease. This initial VE made Moderna's COVID vaccine a slam dunk for Emergency Use Authorization in the United States.</p>\n<p>When the company announced its second-quarter operating results on Aug. 5, it stuck to its original forecast of delivering between 800 million and 1 billion doses in 2021, with net product sales of around $20 billion. Next year, Moderna believes it can provide between 2 billion and 3 billion doses. As a reminder, the Moderna vaccine is a two-dose regimen, meaning its 2022 output could fully inoculate 1 billion to 1.5 billion people.</p>\n<p>Also working in Modena's favor is the possibility of booster vaccinations. The mutability of COVID, coupled with a handful of studies suggesting that VE begins waning at the six-month mark, could create a recurring vaccination need globally.</p>\n<p>While Moderna might sound like a surefire growth story, there are still big question marks about its future. For example, even though mRNA-1273 has been wildly successful, it's the only therapy that's generating sales for the company. Moderna's non-COVID pipeline looks to be years away from bringing in meaningful revenue.</p>\n<p>Equally concerning is the likelihood that the COVID vaccine space is going to become crowded. At some point soon, <b>Novavax</b> should join the field with a formidable initial VE of about 90%. It is also working on a combination COVID/influenza vaccine, which would be a differentiator and game changer.</p>\n<p>Not to take anything away from what Moderna has done, but a $150 billion market cap for a company with a single therapy seems awfully risky.</p>\n<h2><a href=\"https://laohu8.com/S/ZGNX\">Zogenix</a>: Implied sales increase of 2,451%</h2>\n<p>Another biotech stock that's expected to generate jaw-dropping sales growth through 2023 is small-cap <b>Zogenix</b> (NASDAQ:ZGNX). If Wall Street's consensus estimate proves accurate, the company's $13.64 million in reported sales in 2020 could grow to $348 million by 2023.</p>\n<p>Like Moderna, there's a single drug that looks to do all of the heavy lifting for Zogenix over the next couple of years: Fintepla. This is a drug targeted at a variety of seizure-related indications. It's already been approved by the Food and Drug Administration to treat Dravet syndrome. And Zogenix has plans to file a supplemental new drug application by the end of the current quarter to expand Fintepla's label to include Lennox-Gastaut syndrome (LGS). Both Dravet and LGS are rare forms of childhood-onset epilepsy. If approved, Zogenix could launch Fintepla for LGS patients in this country by as early as the first half of 2022.</p>\n<p>And Zogenix still isn't done with Fintepla. After hashing out the finer points with the FDA, the company intends to initiate a phase 3 study involving Fintepla as a treatment for CDKL5 deficiency disorder before the end of the year. Thus, organic growth and label expansion opportunities are expected to fuel sales of Fintepla to almost $350 million in three years.</p>\n<p>What'll be particularly interesting is how Zogenix fares against cannabinoid-focused drug developer GW Pharmaceuticals, which was acquired by <b>Jazz Pharmaceuticals</b> (NASDAQ:JAZZ) in May. GW's lead drug, Epidiolex, is a cannabidiol-based treatment that's been approved by the FDA to treat Dravet syndrome and LGS, and it launched in advance of Zogenix's Fintepla. For comparative purposes, Jazz announced that Epidiolex brought home $155.9 million in sales just in the second quarter, although it has an additional indication under its belt (tuberous sclerosis complex) where it won't compete against Zogenix.</p>\n<p>Although Epidiolex appears to have the upper hand now, it's worth noting that seizure-reduction efficacy for Fintepla looked very promising in late-stage clinical trials. To be 100% clear, the GW Pharma and Zogenix studies were never pitted head-to-head, and their baseline parameters are different. Nevertheless, Fintepla led to a 62.3% reduction in mean monthly convulsive seizure frequency compared to placebo at the six-week mark for Dravet syndrome patients.</p>\n<p>Comparatively, Jazz's Epidiolex demonstrated reductions in seizure frequency from baseline of 56% and 47%, respectively, for the lower- and higher-dose treatments in phase 3 studies in Dravet syndrome patients. Suffice it to say, these could be highly competitive indications for the foreseeable future.</p>\n<h2>Marathon Digital Holdings: Implied sales increase of 12,629%</h2>\n<p>Now, if you want pedal-to-the-metal growth, look no further than <b>Marathon Digital Holdings</b> (NASDAQ:MARA). After reporting a meager $4.36 million in sales in 2020, Wall Street anticipates full-year sales will climb to $555 million by 2023. That's an increase of 12,629%.</p>\n<p>If you're wondering how sales growth of this magnitude is possible for a company not involved in drug development, look no further than cryptocurrencies.</p>\n<p>Marathon Digital is a cryptocurrency mining company. It operates a farm of high-powered computing devices designed to solve complex mathematical equations that validate groups of transactions (known as a block) as valid on a digital currency's blockchain. For being the first to validate a block, Marathon is paid a block reward. This reward is typically a set amount of digital tokens from the digital currency being mined.</p>\n<p>In Marathon's case, it's mining <b>Bitcoin</b> (CRYPTO:BTC), the largest cryptocurrency in the world by market cap. Being the first to mine a Bitcoin block results in the company being awarded 6.25 Bitcoin tokens, which were worth a cool $292,000, as of Aug. 30.</p>\n<p>The reason Marathon's sales are skyrocketing so quickly is because it's in the midst of deploying <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest Bitcoin-mining operations in the United States. As of the beginning of August, approximately 30,100 miners were operating, with another 103,000 ordered and yet to be installed. By the end of the first quarter of 2022, Marathon should have north of 100,000 miners in operation, with all 133,120 up and running by July 2022.</p>\n<p>Though Marathon is the fastest-growing of these three hypergrowth stocks, it's also arguably the most dangerous investment of this trio. That's because it's entirely dependent on external factors, such as interest in, and the price of, Bitcoin -- and not innovation.</p>\n<p>What's more, the barrier to entry in the cryptocurrency mining space is virtually nonexistent. As time passes, it's going to be tougher for Marathon to successfully mine Bitcoin.</p>\n<p>As the icing on the cake, Bitcoin's block rewards halve every four years. By 2024, only 3.125 Bitcoin tokens will be paid for validating a block. Essentially, Marathon is competing against a growing number of mining companies for a reward that's shrinking. It simply doesn't sound like an operating model with long-term staying power.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023\n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-03 22:18 GMT+8 <a href=\"https://www.fool.com/investing/2021/09/03/3-hypergrowth-stocks-increase-sales-1185-to-12629/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Since the end of the Great Recession in 2009, growth stocks have thrived. Historically low lending rates, an ongoing quantitative easing program designed to weigh down long-term bond yields, and a ...</p>\n<a href=\"https://www.fool.com/investing/2021/09/03/3-hypergrowth-stocks-increase-sales-1185-to-12629/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/09/03/3-hypergrowth-stocks-increase-sales-1185-to-12629/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164879370","content_text":"Since the end of the Great Recession in 2009, growth stocks have thrived. Historically low lending rates, an ongoing quantitative easing program designed to weigh down long-term bond yields, and a free-spending Congress have all helped to make cheap capital widely abundant for businesses. This is helping to fuel acquisitions, hiring, and (most importantly) innovation.\nYet for some companies, their exponential growth is just beginning. For each of the following hypergrowth stocks, Wall Street's consensus sales estimate for 2023, courtesy of FactSet, implies a revenue increase ranging from a low of 1,185% (yes, a low of 1,185%) to a high of 12,629%, compared to 2020 sales.\nModerna: Implied sales increase of 1,185%\nArguably the best-known name on this list is biotech Moderna (NASDAQ:MRNA). According to Wall Street, Moderna's annual revenue is expected to catapult from the $803.4 million recorded in 2020 to an estimated $10.33 billion in 2023. Interestingly, the $10.33 billion in projected sales for 2023 is about half of the $20.13 billion forecast this year.\nAs a lot of you probably know, Modena's success is tied to the development of its coronavirus vaccine mRNA-1273. When the company ran a large-scale study of its COVID-19 vaccine, the results (released in November) demonstrated a vaccine efficacy (VE) of 94% and a strong propensity to keep vaccinated individuals from getting severe forms of the disease. This initial VE made Moderna's COVID vaccine a slam dunk for Emergency Use Authorization in the United States.\nWhen the company announced its second-quarter operating results on Aug. 5, it stuck to its original forecast of delivering between 800 million and 1 billion doses in 2021, with net product sales of around $20 billion. Next year, Moderna believes it can provide between 2 billion and 3 billion doses. As a reminder, the Moderna vaccine is a two-dose regimen, meaning its 2022 output could fully inoculate 1 billion to 1.5 billion people.\nAlso working in Modena's favor is the possibility of booster vaccinations. The mutability of COVID, coupled with a handful of studies suggesting that VE begins waning at the six-month mark, could create a recurring vaccination need globally.\nWhile Moderna might sound like a surefire growth story, there are still big question marks about its future. For example, even though mRNA-1273 has been wildly successful, it's the only therapy that's generating sales for the company. Moderna's non-COVID pipeline looks to be years away from bringing in meaningful revenue.\nEqually concerning is the likelihood that the COVID vaccine space is going to become crowded. At some point soon, Novavax should join the field with a formidable initial VE of about 90%. It is also working on a combination COVID/influenza vaccine, which would be a differentiator and game changer.\nNot to take anything away from what Moderna has done, but a $150 billion market cap for a company with a single therapy seems awfully risky.\nZogenix: Implied sales increase of 2,451%\nAnother biotech stock that's expected to generate jaw-dropping sales growth through 2023 is small-cap Zogenix (NASDAQ:ZGNX). If Wall Street's consensus estimate proves accurate, the company's $13.64 million in reported sales in 2020 could grow to $348 million by 2023.\nLike Moderna, there's a single drug that looks to do all of the heavy lifting for Zogenix over the next couple of years: Fintepla. This is a drug targeted at a variety of seizure-related indications. It's already been approved by the Food and Drug Administration to treat Dravet syndrome. And Zogenix has plans to file a supplemental new drug application by the end of the current quarter to expand Fintepla's label to include Lennox-Gastaut syndrome (LGS). Both Dravet and LGS are rare forms of childhood-onset epilepsy. If approved, Zogenix could launch Fintepla for LGS patients in this country by as early as the first half of 2022.\nAnd Zogenix still isn't done with Fintepla. After hashing out the finer points with the FDA, the company intends to initiate a phase 3 study involving Fintepla as a treatment for CDKL5 deficiency disorder before the end of the year. Thus, organic growth and label expansion opportunities are expected to fuel sales of Fintepla to almost $350 million in three years.\nWhat'll be particularly interesting is how Zogenix fares against cannabinoid-focused drug developer GW Pharmaceuticals, which was acquired by Jazz Pharmaceuticals (NASDAQ:JAZZ) in May. GW's lead drug, Epidiolex, is a cannabidiol-based treatment that's been approved by the FDA to treat Dravet syndrome and LGS, and it launched in advance of Zogenix's Fintepla. For comparative purposes, Jazz announced that Epidiolex brought home $155.9 million in sales just in the second quarter, although it has an additional indication under its belt (tuberous sclerosis complex) where it won't compete against Zogenix.\nAlthough Epidiolex appears to have the upper hand now, it's worth noting that seizure-reduction efficacy for Fintepla looked very promising in late-stage clinical trials. To be 100% clear, the GW Pharma and Zogenix studies were never pitted head-to-head, and their baseline parameters are different. Nevertheless, Fintepla led to a 62.3% reduction in mean monthly convulsive seizure frequency compared to placebo at the six-week mark for Dravet syndrome patients.\nComparatively, Jazz's Epidiolex demonstrated reductions in seizure frequency from baseline of 56% and 47%, respectively, for the lower- and higher-dose treatments in phase 3 studies in Dravet syndrome patients. Suffice it to say, these could be highly competitive indications for the foreseeable future.\nMarathon Digital Holdings: Implied sales increase of 12,629%\nNow, if you want pedal-to-the-metal growth, look no further than Marathon Digital Holdings (NASDAQ:MARA). After reporting a meager $4.36 million in sales in 2020, Wall Street anticipates full-year sales will climb to $555 million by 2023. That's an increase of 12,629%.\nIf you're wondering how sales growth of this magnitude is possible for a company not involved in drug development, look no further than cryptocurrencies.\nMarathon Digital is a cryptocurrency mining company. It operates a farm of high-powered computing devices designed to solve complex mathematical equations that validate groups of transactions (known as a block) as valid on a digital currency's blockchain. For being the first to validate a block, Marathon is paid a block reward. This reward is typically a set amount of digital tokens from the digital currency being mined.\nIn Marathon's case, it's mining Bitcoin (CRYPTO:BTC), the largest cryptocurrency in the world by market cap. Being the first to mine a Bitcoin block results in the company being awarded 6.25 Bitcoin tokens, which were worth a cool $292,000, as of Aug. 30.\nThe reason Marathon's sales are skyrocketing so quickly is because it's in the midst of deploying one of the largest Bitcoin-mining operations in the United States. As of the beginning of August, approximately 30,100 miners were operating, with another 103,000 ordered and yet to be installed. By the end of the first quarter of 2022, Marathon should have north of 100,000 miners in operation, with all 133,120 up and running by July 2022.\nThough Marathon is the fastest-growing of these three hypergrowth stocks, it's also arguably the most dangerous investment of this trio. That's because it's entirely dependent on external factors, such as interest in, and the price of, Bitcoin -- and not innovation.\nWhat's more, the barrier to entry in the cryptocurrency mining space is virtually nonexistent. As time passes, it's going to be tougher for Marathon to successfully mine Bitcoin.\nAs the icing on the cake, Bitcoin's block rewards halve every four years. By 2024, only 3.125 Bitcoin tokens will be paid for validating a block. Essentially, Marathon is competing against a growing number of mining companies for a reward that's shrinking. It simply doesn't sound like an operating model with long-term staying power.","news_type":1},"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818703329,"gmtCreate":1630445638661,"gmtModify":1676530302941,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818703329","repostId":"1143612003","repostType":4,"repost":{"id":"1143612003","kind":"news","pubTimestamp":1630367966,"share":"https://ttm.financial/m/news/1143612003?lang=&edition=full_marsco","pubTime":"2021-08-31 07:59","market":"us","language":"en","title":"GameStop Stock Rally Passes by Some Previous Winners","url":"https://stock-news.laohu8.com/highlight/detail?id=1143612003","media":"The Wall Street Journal","summary":"A number of exchange-traded funds that benefited from the early-year surge in meme stocks have since","content":"<html><body><blockquote>\n<b>A number of exchange-traded funds that benefited from the early-year surge in meme stocks have since backed away.</b>\n</blockquote>\n<p>Many exchange-traded funds that scored big on the meme-stock craze earlier this year are missing out on large gains this time around.</p>\n<p><a href=\"https://laohu8.com/S/STT\">State</a> Street’sSPDR S&P Retail ETFhad roughly <a href=\"https://laohu8.com/S/AONE.U\">one</a>-fifth of its assets inGameStopGME2.07%earlier this year, helping it score a 37% return in January. But by August, <a href=\"https://laohu8.com/S/GME\">GameStop</a> shares represented less than 1% of the fund’s assets. So when the stock took flight again last week, rising nearly 30%, the ETF gained just 2%.</p>\n<p>The results underscore the swirling dynamics facing fund managers and others at a time of outsize gains in a handful of red-hot stocks. While some ETFs that invested in these firms last year have continued to reap gains, others have retreated from the shares in a bid to reduce risk and ended up missing out on fresh windfalls, potentially pressuring performance.</p>\n<p>“A lot of people say we’re capping the upside, but we’re also mitigating the downside of a single stock that could blow up your investment thesis,” said Matt Bartolini, head of SPDR Americas Research at State Street Global Advisors.</p>\n<p>State Street’s retail ETF, which trades under the ticker symbol XRT, offers a way for investors to bet on a swath of the retail sector, usually giving roughly equal exposure to GameStop as to the industry juggernaut, <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc.</p>\n<p>A big run-up in a particular stock, like with GameStop, over a brief stretch can dramatically reshape the $1.1 billion fund’s makeup. GameStop’s surge made it XRT’s biggest holding in late January and was the key contributor to the ETF’s best month ever. The position was so big, many traders on Reddit and other social-media sites began pitching the ETF as a way to play GameStop when some brokerages blocked users from trading shares.</p>\n<p>GameStop’s big weight also made it a liability a month later: Shares of the videogame retailer fell nearly 70% in February, pulling XRT down 10%.</p>\n<p>When the ETF conducted its quarterly rebalance in March, XRT sold enough GameStop shares to bring the stock’s weighting in line with the other holdings. Immediately, the fund’s moves were more subdued even as GameStop shares continued to swing.</p>\n<p>Performance also has been more muted. XRT shares are little changed this month even as GameStop’s are up 30%.</p>\n<p>The ETF is “meant to provide exposure to the retail industry. One security shouldn’t dominate the returns,” said Mr. Bartolini. Maintaining broad exposure to all of the fund’s holdings is a goal for the ETF and part of why it isn’t weighted by market capitalization, he said.</p>\n<p>A videogame ETF run by Wedbush and ETFMG also cut back on its hefty GameStop position. Shares of theWedbush ETFMG Video Game Tech ETF, or GAMR, rose 36% in January. The videogame ETF sold GameStop stock in March and led the fund to impose a 15% ceiling on any one holding, said Ted Pollak, founder and president of GAMR’s index provider.</p>\n<p><a href=\"https://laohu8.com/S/IVZ\">Invesco</a>’s$1.4 billionDynamic Leisure and Entertainment ETFsold all of itsAMC Entertainment Holdingsshares on June 2 after the position ballooned to 18% of the fund’s assets from 2.7% in March. The reason: The movie-theater chain no longer met the index’s criteria for inclusion.</p>\n<p>The decision has paid off for fundholders, the firm says. While the ETF is down 5% since the rebalancing, AMC shares have fallen about 16%.</p>\n<p>“It’s a challenging situation for a person to sell on that particular day having seen the stock up more than six times,” said John Hoffman, Invesco’s head of ETFs and indexed strategies for the Americas. “ETFs take some of the emotion out of the process.”</p>\n<p></p>\n<p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>GameStop Stock Rally Passes by Some Previous Winners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Stock Rally Passes by Some Previous Winners\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-31 07:59 GMT+8 <a href=\"https://www.wsj.com/articles/gamestop-stock-rally-passes-by-some-previous-winners-11630324981?mod=markets_lead_pos4\"><strong>The Wall Street Journal</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>A number of exchange-traded funds that benefited from the early-year surge in meme stocks have since backed away.\n\nMany exchange-traded funds that scored big on the meme-stock craze earlier this year ...</p>\n<a href=\"https://www.wsj.com/articles/gamestop-stock-rally-passes-by-some-previous-winners-11630324981?mod=markets_lead_pos4\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://www.wsj.com/articles/gamestop-stock-rally-passes-by-some-previous-winners-11630324981?mod=markets_lead_pos4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143612003","content_text":"A number of exchange-traded funds that benefited from the early-year surge in meme stocks have since backed away.\n\nMany exchange-traded funds that scored big on the meme-stock craze earlier this year are missing out on large gains this time around.\nState Street’sSPDR S&P Retail ETFhad roughly one-fifth of its assets inGameStopGME2.07%earlier this year, helping it score a 37% return in January. But by August, GameStop shares represented less than 1% of the fund’s assets. So when the stock took flight again last week, rising nearly 30%, the ETF gained just 2%.\nThe results underscore the swirling dynamics facing fund managers and others at a time of outsize gains in a handful of red-hot stocks. While some ETFs that invested in these firms last year have continued to reap gains, others have retreated from the shares in a bid to reduce risk and ended up missing out on fresh windfalls, potentially pressuring performance.\n“A lot of people say we’re capping the upside, but we’re also mitigating the downside of a single stock that could blow up your investment thesis,” said Matt Bartolini, head of SPDR Americas Research at State Street Global Advisors.\nState Street’s retail ETF, which trades under the ticker symbol XRT, offers a way for investors to bet on a swath of the retail sector, usually giving roughly equal exposure to GameStop as to the industry juggernaut, Amazon.com Inc.\nA big run-up in a particular stock, like with GameStop, over a brief stretch can dramatically reshape the $1.1 billion fund’s makeup. GameStop’s surge made it XRT’s biggest holding in late January and was the key contributor to the ETF’s best month ever. The position was so big, many traders on Reddit and other social-media sites began pitching the ETF as a way to play GameStop when some brokerages blocked users from trading shares.\nGameStop’s big weight also made it a liability a month later: Shares of the videogame retailer fell nearly 70% in February, pulling XRT down 10%.\nWhen the ETF conducted its quarterly rebalance in March, XRT sold enough GameStop shares to bring the stock’s weighting in line with the other holdings. Immediately, the fund’s moves were more subdued even as GameStop shares continued to swing.\nPerformance also has been more muted. XRT shares are little changed this month even as GameStop’s are up 30%.\nThe ETF is “meant to provide exposure to the retail industry. One security shouldn’t dominate the returns,” said Mr. Bartolini. Maintaining broad exposure to all of the fund’s holdings is a goal for the ETF and part of why it isn’t weighted by market capitalization, he said.\nA videogame ETF run by Wedbush and ETFMG also cut back on its hefty GameStop position. Shares of theWedbush ETFMG Video Game Tech ETF, or GAMR, rose 36% in January. The videogame ETF sold GameStop stock in March and led the fund to impose a 15% ceiling on any one holding, said Ted Pollak, founder and president of GAMR’s index provider.\nInvesco’s$1.4 billionDynamic Leisure and Entertainment ETFsold all of itsAMC Entertainment Holdingsshares on June 2 after the position ballooned to 18% of the fund’s assets from 2.7% in March. The reason: The movie-theater chain no longer met the index’s criteria for inclusion.\nThe decision has paid off for fundholders, the firm says. While the ETF is down 5% since the rebalancing, AMC shares have fallen about 16%.\n“It’s a challenging situation for a person to sell on that particular day having seen the stock up more than six times,” said John Hoffman, Invesco’s head of ETFs and indexed strategies for the Americas. “ETFs take some of the emotion out of the process.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818700150,"gmtCreate":1630445380370,"gmtModify":1676530302910,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818700150","repostId":"2163185185","repostType":4,"repost":{"id":"2163185185","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1630419960,"share":"https://ttm.financial/m/news/2163185185?lang=&edition=full_marsco","pubTime":"2021-08-31 22:26","market":"us","language":"en","title":"The S&P 500 is headed for 5,000, says UBS. Here's the when and how.","url":"https://stock-news.laohu8.com/highlight/detail?id=2163185185","media":"Dow Jones","summary":"On the last trading day of August, stock futures are pointing higher as markets look past downbeat e","content":"<html><body><p>On the last trading day of August, stock futures are pointing higher as markets look past downbeat economic news from China and continued COVID-19 contagion worries. It's all part of a relentless march higher for stocks that barely paused this summer.</p>\n<p>\"The S&P 500 has posted at least 1 new closing high every week since the week of June 7, 2021, 13 weeks in a row. August 2021 has posted 12 new closing highs in the 21 trading days, with <a href=\"https://laohu8.com/S/AONE.U\">one</a> day left to go,\" noted Howard Silverblatt, senior index analyst at S&P Dow Jones Indices.</p>\n<p>\"Year-to-date the index has posted 53 new closing highs, and is tied for the 4 highest in index history (from 1926),\" added Silverblatt, who added that even if the market seems wacky, \"if you're not in it, you're nuts, and most likely out of a job (keep your finger on the button).\"</p>\n<p>Our call of the day from UBS's chief investment officer Mark Haefele, sees the S&P 500 is on a solid path to another big milestone -- 5,000. That's his end-2022 goal, while the bank sees the index reaching 4,600 by the end of this year.</p>\n<p>\"The S&P 500 has broken above 4,500 for the first time, taking gains for 2021 to over 20%. This might seem surprising given the recent run of negative news, including disappointing U.S. consumer data and a continual rise in COVID-19 infections. But we believe that the momentum toward reopening and recovery is intact and that there is further upside to equities,\" Haefele told clients in a note.</p>\n<p>He rattles off a list of supportive factors, including a fifth-straight quarter of robust results with more than 85% of companies beating second-quarter earnings and sales estimates; aggregate corporate profits up nearly 90% from year-ago levels; earnings nearly 30% higher than pre-pandemic levels; and revenue growth so robust it's overwhelming cost pressures.</p>\n<p>\"We believe cost pressures for businesses should subside as supply begins to catch up. In addition, consumers' balance sheets are at their strongest in decades due to the significant buildup in household savings over the past year, and retailers will continue to restock to keep up with demand,\" said Haefele.</p>\n<p>Show us the stocks? \"With the economic recovery broadening, we expect cyclical sectors, including energy and financials, to take the lead,\" he added.</p>\n<p><b>The chart</b></p>\n<p>Thomas Lee, founder of Fundstrat Global Advisors, notes that history is on the side of a strong September when markets see an equally upbeat first half.</p>\n<p>That's even as investors worry about \"overbought\" markets due for a pullback and stats showing September returns since 1928 have been down about 0.1%. In a note to clients, Lee counters that seasonality factors change when a first half is strong -- the first six months of 2021 saw a more than 13% gain, the 10th best since 1928.</p>\n<p>That should mean a stronger September than expected and an intact \"everything rally.\" Here's his chart:</p>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/7ee49b4bca8dd1180df5c66c2370394f\" tg-height=\"486\" tg-width=\"700\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>The S&P 500 is headed for 5,000, says UBS. Here's the when and how.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 is headed for 5,000, says UBS. Here's the when and how.\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-31 22:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>On the last trading day of August, stock futures are pointing higher as markets look past downbeat economic news from China and continued COVID-19 contagion worries. It's all part of a relentless march higher for stocks that barely paused this summer.</p>\n<p>\"The S&P 500 has posted at least 1 new closing high every week since the week of June 7, 2021, 13 weeks in a row. August 2021 has posted 12 new closing highs in the 21 trading days, with <a href=\"https://laohu8.com/S/AONE.U\">one</a> day left to go,\" noted Howard Silverblatt, senior index analyst at S&P Dow Jones Indices.</p>\n<p>\"Year-to-date the index has posted 53 new closing highs, and is tied for the 4 highest in index history (from 1926),\" added Silverblatt, who added that even if the market seems wacky, \"if you're not in it, you're nuts, and most likely out of a job (keep your finger on the button).\"</p>\n<p>Our call of the day from UBS's chief investment officer Mark Haefele, sees the S&P 500 is on a solid path to another big milestone -- 5,000. That's his end-2022 goal, while the bank sees the index reaching 4,600 by the end of this year.</p>\n<p>\"The S&P 500 has broken above 4,500 for the first time, taking gains for 2021 to over 20%. This might seem surprising given the recent run of negative news, including disappointing U.S. consumer data and a continual rise in COVID-19 infections. But we believe that the momentum toward reopening and recovery is intact and that there is further upside to equities,\" Haefele told clients in a note.</p>\n<p>He rattles off a list of supportive factors, including a fifth-straight quarter of robust results with more than 85% of companies beating second-quarter earnings and sales estimates; aggregate corporate profits up nearly 90% from year-ago levels; earnings nearly 30% higher than pre-pandemic levels; and revenue growth so robust it's overwhelming cost pressures.</p>\n<p>\"We believe cost pressures for businesses should subside as supply begins to catch up. In addition, consumers' balance sheets are at their strongest in decades due to the significant buildup in household savings over the past year, and retailers will continue to restock to keep up with demand,\" said Haefele.</p>\n<p>Show us the stocks? \"With the economic recovery broadening, we expect cyclical sectors, including energy and financials, to take the lead,\" he added.</p>\n<p><b>The chart</b></p>\n<p>Thomas Lee, founder of Fundstrat Global Advisors, notes that history is on the side of a strong September when markets see an equally upbeat first half.</p>\n<p>That's even as investors worry about \"overbought\" markets due for a pullback and stats showing September returns since 1928 have been down about 0.1%. In a note to clients, Lee counters that seasonality factors change when a first half is strong -- the first six months of 2021 saw a more than 13% gain, the 10th best since 1928.</p>\n<p>That should mean a stronger September than expected and an intact \"everything rally.\" Here's his chart:</p>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/7ee49b4bca8dd1180df5c66c2370394f\" tg-height=\"486\" tg-width=\"700\"/></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2163185185","content_text":"On the last trading day of August, stock futures are pointing higher as markets look past downbeat economic news from China and continued COVID-19 contagion worries. It's all part of a relentless march higher for stocks that barely paused this summer.\n\"The S&P 500 has posted at least 1 new closing high every week since the week of June 7, 2021, 13 weeks in a row. August 2021 has posted 12 new closing highs in the 21 trading days, with one day left to go,\" noted Howard Silverblatt, senior index analyst at S&P Dow Jones Indices.\n\"Year-to-date the index has posted 53 new closing highs, and is tied for the 4 highest in index history (from 1926),\" added Silverblatt, who added that even if the market seems wacky, \"if you're not in it, you're nuts, and most likely out of a job (keep your finger on the button).\"\nOur call of the day from UBS's chief investment officer Mark Haefele, sees the S&P 500 is on a solid path to another big milestone -- 5,000. That's his end-2022 goal, while the bank sees the index reaching 4,600 by the end of this year.\n\"The S&P 500 has broken above 4,500 for the first time, taking gains for 2021 to over 20%. This might seem surprising given the recent run of negative news, including disappointing U.S. consumer data and a continual rise in COVID-19 infections. But we believe that the momentum toward reopening and recovery is intact and that there is further upside to equities,\" Haefele told clients in a note.\nHe rattles off a list of supportive factors, including a fifth-straight quarter of robust results with more than 85% of companies beating second-quarter earnings and sales estimates; aggregate corporate profits up nearly 90% from year-ago levels; earnings nearly 30% higher than pre-pandemic levels; and revenue growth so robust it's overwhelming cost pressures.\n\"We believe cost pressures for businesses should subside as supply begins to catch up. In addition, consumers' balance sheets are at their strongest in decades due to the significant buildup in household savings over the past year, and retailers will continue to restock to keep up with demand,\" said Haefele.\nShow us the stocks? \"With the economic recovery broadening, we expect cyclical sectors, including energy and financials, to take the lead,\" he added.\nThe chart\nThomas Lee, founder of Fundstrat Global Advisors, notes that history is on the side of a strong September when markets see an equally upbeat first half.\nThat's even as investors worry about \"overbought\" markets due for a pullback and stats showing September returns since 1928 have been down about 0.1%. In a note to clients, Lee counters that seasonality factors change when a first half is strong -- the first six months of 2021 saw a more than 13% gain, the 10th best since 1928.\nThat should mean a stronger September than expected and an intact \"everything rally.\" Here's his chart:","news_type":1},"isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819459139,"gmtCreate":1630099701621,"gmtModify":1676530222872,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819459139","repostId":"2162042478","repostType":4,"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835785479,"gmtCreate":1629755414491,"gmtModify":1676530118609,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835785479","repostId":"1103523722","repostType":4,"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835940125,"gmtCreate":1629685263667,"gmtModify":1676530098212,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835940125","repostId":"2161747692","repostType":4,"repost":{"id":"2161747692","kind":"news","pubTimestamp":1629673828,"share":"https://ttm.financial/m/news/2161747692?lang=&edition=full_marsco","pubTime":"2021-08-23 07:10","market":"us","language":"en","title":"Fed's Jackson Hole Symposium, personal income and spending: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2161747692","media":"Yahoo Finance","summary":"Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at","content":"<html><body><p>Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at the bank's annual Jackson Hole Economic Policy Symposium.</p>\n<p>The event, which takes place from Thursday to Saturday this week, is set to serve as a forum for more discussions around Fed policymakers' plans to announce and implement a shift in the central bank's monetary policy stance. Namely, investors have been closely watching for months to hear when officials will begin tapering their purchases of Treasury and mortgage securities, which have been taking place at a pace of $120 billion per month for more than a year during the pandemic.</p>\n<p>This asset purchase program had been a major policy underpinning U.S. equity markets this year, providing liquidity throughout the economic crisis induced by the virus. But as the economy makes headway in recovering, Fed officials' talk around pulling in the reins on this program has started to increase.</p>\n<p>Last week, Federal Reserve officials signaled the announcement of the start of tapering was edging closer. According to the meeting minutes from the Federal Reserve's July meeting, most monetary policymakers believed the economy will have made enough progress toward recovering to warrant tapering.</p>\n<p>\"Most participants noted that, provided that the economy were to evolve broadly as they anticipated, they judged that it could be appropriate to start reducing the pace of asset purchases this year because they saw the Committee’s 'substantial further progress' criterion as satisfied with respect to the price-stability goal and as close to being satisfied with respect to the maximum employment goal,\" according to the FOMC minutes.</p>\n<p>But as many pundits have noted, the central bank still has a host of meetings left in 2021 to serve as a platform for further discussing or announcing tapering. As a result, Jackson Hole this week may cause few ripples, with policymakers like Federal Reserve Chair Jerome Powell sticking to their previously telegraphed language about waiting to see further improvements in the labor market before escalating talk of tapering further.</p>\n<p>\"Jackson Hole next week is certainly a target for when we might hear some actual firm language around taper. I'm not really expecting much out of Jackson Hole,\" Garrett Melson, Natixis Investment Managers Solutions portfolio strategist, told Yahoo Finance last week. \"We're more in the camp that we probably start to hear something around the November meeting. Perhaps they're as quick as December to start actually implementing the taper. But I'm still more in the camp that January is probably when we begin to see a slow taper, probably in the ballpark of $15 billion per month.\"</p>\n<p>\"They're still very, very dovish. They're slightly less dovish,\" he added. \"But that's a little semantics at this point. Taper is very well documented and well known. We know it's coming. It's just a matter of timing and really shouldn't surprise many investors out there.\"</p>\n<p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/ffd135dd0d8cdc399e0982d54e39f5bd\" tg-height=\"4000\" tg-width=\"6000\" width=\"100%\"/><span>Federal Reserve Board Chair Jerome Powell testifies before Senate Banking, Housing, and Urban Affairs hearing to examine the Semiannual Monetary Policy Report to Congress, July 15, 2021, on Capitol Hill. (AP Photo/Jose Luis Magana, file)ASSOCIATED PRESS</span></p>\n<p>As for the ultimate market impact of tapering, if the outcome is anything like the response from the last announcement of tapering in 2023, investors might brace for a momentary bout of volatility and some sector rotation beneath the surface.</p>\n<p>\"In 2013, Fed Chair Bernanke's comments about tapering catalyzed a five-day, 40 bp backup in 10-year yields and a 5% drop in the S&P 500,\" said David Kostin, Goldman Sachs' chief U.S. equity strategist, in a note last week. \"The initial signal from the taper tantrum ultimately proved fleeting during a year with extremely strong returns for equities.\"</p>\n<p>\"The S&P 500 rebounded 5% in the roughly two months following the tantrum, led higher by the materials, consumer discretionary, and health care sectors,\" he added. \"By December, the S&P 500 had posted a full-year return of 32%. As the Fed reiterated its commitment to accommodative policy, growth outperformed value and cyclical stocks outperformed defensives.\"</p>\n<h2>Personal spending, income</h2>\n<p>New economic data on consumer spending and income will also be in focus later this week, with reports on both metrics due for release on Friday.</p>\n<p>Consensus economists expect to see personal spending slow to just a 0.4% monthly clip in July, decelerating from June's 1.0% increase.</p>\n<p>Just last week, the Commerce Department's data showed retail sales fell more than expected in July, dipping by 1.1%. The print pointed to more moderation in spending as the impact of stimulus checks earlier this year waned further, and lowered the bar for the Bureau of Economic Analysis' monthly personal spending data.</p>\n<p>Other data has also underscored the slowdown in consumer spending, especially given the recent spread of the Delta variant starting in the middle of summer.</p>\n<p>\"Although services spending started strong in July boosted by the holiday, our aggregated BAC credit and debit card data suggest services spending, particularly for travel and leisure, slowed down noticeably in the second half of the month, potentially due to rising Delta concerns,\" Bank of America economist Michelle Meyer wrote in a note Friday.</p>\n<p>Friday's consumer spending report will also come with data on personal income, which is also expected to have ticked up only slightly on a monthly basis. Economists look for a 0.1% increase in July, which would match the pace from the prior month.</p>\n<p>Even with the deceleration in income, however, the personal savings rate may have increased as an early round of child tax credit payments helped offset a slowing pace of income growth, some economists noted.</p>\n<p>\"The advance child tax credit payments delivered this month translated into a lower tax burden and therefore a 1% month-over-month boost to disposable income, consequently leading to a rise in the savings rate to 10.0% from 9.4% in June,\" Meyer predicted.</p>\n<h2>Economic calendar</h2>\n<ul>\n<li><p><b>Monday: </b>Chicago Fed National Activity Index, July (0.09 in June); <a href=\"https://laohu8.com/S/MRKT\">Markit</a> U.S. Manufacturing PMI, August preliminary (62.8 expected, 63.4 in July); Markit U.S. Services PMI, August preliminary (59.0 expected, 59.9 in July); Markit U.S. Composite PMI, August preliminary (59.9 in July); Existing home sales, month-on-month, July (-0.3% expected, 1.4% in June)</p></li>\n<li><p><b>Tuesday: </b>Richmond Fed Manufacturing Index, August (25 expected, 27 in July); New home sales, month-on-month, July (3.6% expected, -6.6% in June)</p></li>\n<li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended August 20 (-3.9% during prior week); Durable goods orders, July preliminary (-0.2% expected, 0.9% in June); Non-defense capital goods orders excluding aircraft, July preliminary (0.5% expected, 0.7% in June); Non-defense capital goods shipments excluding aircraft, July preliminary (0.6% in June)</p></li>\n<li><p><b>Thursday: </b>Initial jobless claims, week ended August 21 (352,000 expected, 348,000 during prior week); Continuing claims, week ended August 14 (2.780 million expected, 2.820 million during prior week); GDP annualized quarter-over-quarter, Q2 second estimate (6.6% expected, 6.5% in prior print); Personal consumption, Q2 second estimate (12.3% expected, 11.8% in prior print); Core PCE quarter-over-quarter Q2 second estimate (6.1% expected, 6.1% in prior print); Kansas City Fed Manufacturing Activity Index, August (30 in prior print)</p></li>\n<li><p><b>Friday: </b>Advanced goods trade balance, July (-$90.9 billion expected, -$91.2 billion in June); Wholesale inventories, month-over-month, July preliminary (1.0% expected, 1.1% in June); Personal income, July (0.2% expected, 0.1% in June); Personal spending, July (0.4% expected, 1.0% in June); PCE core deflator, month-on-month, July (0.3% expected, 0.4% in June); PCE core deflator, year-on-year, July (3.6% expected, 3.5% in June); University of Michigan Sentiment, August final (71.0 expected, 70.2 in prior print)</p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n<li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n<li><p><b>Tuesday: </b>Advance Auto Parts (AAP) before market open; Intuit (INTU) after market close</p></li>\n<li><p><b>Wednesday: </b>Best Buy (BBY) before market open; <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> (CRM), Autodesk (ADSK), Ulta Beauty (ULTA) after market close</p></li>\n<li><p><b>Thursday: </b>The JM Smucker Co. (SJM), Dollar General (DG), Dollar Tree (DLTR) before market open; The Gap (GPS), HP Inc. (HPQ) after market close</p></li>\n<li><p><b>Friday: </b><i>No notable reports scheduled for release </i></p></li>\n</ul></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Fed's Jackson Hole Symposium, personal income and spending: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed's Jackson Hole Symposium, personal income and spending: What to know this week\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-23 07:10 GMT+8 <a href=\"https://finance.yahoo.com/news/fed-heads-to-jackson-hole-personal-income-and-spending-what-to-know-this-week-150228513.html\"><strong>Yahoo Finance</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at the bank's annual Jackson Hole Economic Policy Symposium.\nThe event, which takes place from ...</p>\n<a href=\"https://finance.yahoo.com/news/fed-heads-to-jackson-hole-personal-income-and-spending-what-to-know-this-week-150228513.html\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGT":"塔吉特","BBY":"百思买","SPY.AU":"SPDR® S&P 500® ETF Trust",".IXIC":"NASDAQ Composite","WMT":"沃尔玛","XRT":"零售指数ETF-SPDR标普",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/fed-heads-to-jackson-hole-personal-income-and-spending-what-to-know-this-week-150228513.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2161747692","content_text":"Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at the bank's annual Jackson Hole Economic Policy Symposium.\nThe event, which takes place from Thursday to Saturday this week, is set to serve as a forum for more discussions around Fed policymakers' plans to announce and implement a shift in the central bank's monetary policy stance. Namely, investors have been closely watching for months to hear when officials will begin tapering their purchases of Treasury and mortgage securities, which have been taking place at a pace of $120 billion per month for more than a year during the pandemic.\nThis asset purchase program had been a major policy underpinning U.S. equity markets this year, providing liquidity throughout the economic crisis induced by the virus. But as the economy makes headway in recovering, Fed officials' talk around pulling in the reins on this program has started to increase.\nLast week, Federal Reserve officials signaled the announcement of the start of tapering was edging closer. According to the meeting minutes from the Federal Reserve's July meeting, most monetary policymakers believed the economy will have made enough progress toward recovering to warrant tapering.\n\"Most participants noted that, provided that the economy were to evolve broadly as they anticipated, they judged that it could be appropriate to start reducing the pace of asset purchases this year because they saw the Committee’s 'substantial further progress' criterion as satisfied with respect to the price-stability goal and as close to being satisfied with respect to the maximum employment goal,\" according to the FOMC minutes.\nBut as many pundits have noted, the central bank still has a host of meetings left in 2021 to serve as a platform for further discussing or announcing tapering. As a result, Jackson Hole this week may cause few ripples, with policymakers like Federal Reserve Chair Jerome Powell sticking to their previously telegraphed language about waiting to see further improvements in the labor market before escalating talk of tapering further.\n\"Jackson Hole next week is certainly a target for when we might hear some actual firm language around taper. I'm not really expecting much out of Jackson Hole,\" Garrett Melson, Natixis Investment Managers Solutions portfolio strategist, told Yahoo Finance last week. \"We're more in the camp that we probably start to hear something around the November meeting. Perhaps they're as quick as December to start actually implementing the taper. But I'm still more in the camp that January is probably when we begin to see a slow taper, probably in the ballpark of $15 billion per month.\"\n\"They're still very, very dovish. They're slightly less dovish,\" he added. \"But that's a little semantics at this point. Taper is very well documented and well known. We know it's coming. It's just a matter of timing and really shouldn't surprise many investors out there.\"\nFederal Reserve Board Chair Jerome Powell testifies before Senate Banking, Housing, and Urban Affairs hearing to examine the Semiannual Monetary Policy Report to Congress, July 15, 2021, on Capitol Hill. (AP Photo/Jose Luis Magana, file)ASSOCIATED PRESS\nAs for the ultimate market impact of tapering, if the outcome is anything like the response from the last announcement of tapering in 2023, investors might brace for a momentary bout of volatility and some sector rotation beneath the surface.\n\"In 2013, Fed Chair Bernanke's comments about tapering catalyzed a five-day, 40 bp backup in 10-year yields and a 5% drop in the S&P 500,\" said David Kostin, Goldman Sachs' chief U.S. equity strategist, in a note last week. \"The initial signal from the taper tantrum ultimately proved fleeting during a year with extremely strong returns for equities.\"\n\"The S&P 500 rebounded 5% in the roughly two months following the tantrum, led higher by the materials, consumer discretionary, and health care sectors,\" he added. \"By December, the S&P 500 had posted a full-year return of 32%. As the Fed reiterated its commitment to accommodative policy, growth outperformed value and cyclical stocks outperformed defensives.\"\nPersonal spending, income\nNew economic data on consumer spending and income will also be in focus later this week, with reports on both metrics due for release on Friday.\nConsensus economists expect to see personal spending slow to just a 0.4% monthly clip in July, decelerating from June's 1.0% increase.\nJust last week, the Commerce Department's data showed retail sales fell more than expected in July, dipping by 1.1%. The print pointed to more moderation in spending as the impact of stimulus checks earlier this year waned further, and lowered the bar for the Bureau of Economic Analysis' monthly personal spending data.\nOther data has also underscored the slowdown in consumer spending, especially given the recent spread of the Delta variant starting in the middle of summer.\n\"Although services spending started strong in July boosted by the holiday, our aggregated BAC credit and debit card data suggest services spending, particularly for travel and leisure, slowed down noticeably in the second half of the month, potentially due to rising Delta concerns,\" Bank of America economist Michelle Meyer wrote in a note Friday.\nFriday's consumer spending report will also come with data on personal income, which is also expected to have ticked up only slightly on a monthly basis. Economists look for a 0.1% increase in July, which would match the pace from the prior month.\nEven with the deceleration in income, however, the personal savings rate may have increased as an early round of child tax credit payments helped offset a slowing pace of income growth, some economists noted.\n\"The advance child tax credit payments delivered this month translated into a lower tax burden and therefore a 1% month-over-month boost to disposable income, consequently leading to a rise in the savings rate to 10.0% from 9.4% in June,\" Meyer predicted.\nEconomic calendar\n\nMonday: Chicago Fed National Activity Index, July (0.09 in June); Markit U.S. Manufacturing PMI, August preliminary (62.8 expected, 63.4 in July); Markit U.S. Services PMI, August preliminary (59.0 expected, 59.9 in July); Markit U.S. Composite PMI, August preliminary (59.9 in July); Existing home sales, month-on-month, July (-0.3% expected, 1.4% in June)\nTuesday: Richmond Fed Manufacturing Index, August (25 expected, 27 in July); New home sales, month-on-month, July (3.6% expected, -6.6% in June)\nWednesday: MBA Mortgage Applications, week ended August 20 (-3.9% during prior week); Durable goods orders, July preliminary (-0.2% expected, 0.9% in June); Non-defense capital goods orders excluding aircraft, July preliminary (0.5% expected, 0.7% in June); Non-defense capital goods shipments excluding aircraft, July preliminary (0.6% in June)\nThursday: Initial jobless claims, week ended August 21 (352,000 expected, 348,000 during prior week); Continuing claims, week ended August 14 (2.780 million expected, 2.820 million during prior week); GDP annualized quarter-over-quarter, Q2 second estimate (6.6% expected, 6.5% in prior print); Personal consumption, Q2 second estimate (12.3% expected, 11.8% in prior print); Core PCE quarter-over-quarter Q2 second estimate (6.1% expected, 6.1% in prior print); Kansas City Fed Manufacturing Activity Index, August (30 in prior print)\nFriday: Advanced goods trade balance, July (-$90.9 billion expected, -$91.2 billion in June); Wholesale inventories, month-over-month, July preliminary (1.0% expected, 1.1% in June); Personal income, July (0.2% expected, 0.1% in June); Personal spending, July (0.4% expected, 1.0% in June); PCE core deflator, month-on-month, July (0.3% expected, 0.4% in June); PCE core deflator, year-on-year, July (3.6% expected, 3.5% in June); University of Michigan Sentiment, August final (71.0 expected, 70.2 in prior print)\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: Advance Auto Parts (AAP) before market open; Intuit (INTU) after market close\nWednesday: Best Buy (BBY) before market open; Salesforce (CRM), Autodesk (ADSK), Ulta Beauty (ULTA) after market close\nThursday: The JM Smucker Co. (SJM), Dollar General (DG), Dollar Tree (DLTR) before market open; The Gap (GPS), HP Inc. (HPQ) after market close\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835954455,"gmtCreate":1629685206777,"gmtModify":1676530098173,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835954455","repostId":"2161747692","repostType":4,"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832896443,"gmtCreate":1629603727582,"gmtModify":1676530077999,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Buy ","listText":"Buy ","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/832896443","repostId":"1189046360","repostType":4,"repost":{"id":"1189046360","kind":"news","pubTimestamp":1629448332,"share":"https://ttm.financial/m/news/1189046360?lang=&edition=full_marsco","pubTime":"2021-08-20 16:32","market":"us","language":"en","title":"Moderna COVID-19 vaccine being probed in U.S. for higher-than-expected risk of side effect","url":"https://stock-news.laohu8.com/highlight/detail?id=1189046360","media":"Seeking Alpha","summary":"(Update: August 20, 2021 at 5:59 a.m. ET)\nThe federal health officials are investigating whether the","content":"<html><body><p><i><b>(Update: August 20, 2021 at 5:59 a.m. ET)</b></i></p>\n<p>The federal health officials are investigating whether the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (NASDAQ: MRNA)is linked to even a higher risk of a rare side effect called myocarditis in younger adults than initially expected, <i>The WashingtonPost</i> reported citing people familiar with the matter.</p>\n<p>The people have stressed that the side effect affecting the heart “probably” continues to be uncommon. The probe has involved the officials from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).</p>\n<p>The investigation is reportedly focused on emerging data from Canada indicating that the vaccine carries a higher risk in the younger population than that from the rival COVID-19 shot from <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (NYSE: PFE) and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (NASDAQ: BNTX), in males below the age of 30 or so in particular.</p>\n<p>The authorities are trying to establish whether the U.S. data also suggest a higher risk from Moderna’s (MRNA) vaccine in the population.</p>\n<li><p>In June, the FDA moved to update the fact sheets of Pfizer (PFE)/ BioNTech (BNTX) and Moderna (MRNA) vaccines to reflect the likelihood of rare cases of heart inflammation following their administration.</p><p>Moderna sink over 2% in premarket trading.</p><p><img height=\"auto\" src=\"https://static.tigerbbs.com/e4e9a64ce0c6eb83275b67dbd3b00b4c\" tg-height=\"391\" tg-width=\"917\" width=\"100%\"/></p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Moderna COVID-19 vaccine being probed in U.S. for higher-than-expected risk of side effect</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna COVID-19 vaccine being probed in U.S. for higher-than-expected risk of side effect\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-20 16:32 GMT+8 <a href=\"https://seekingalpha.com/news/3732568-moderna-covid-19-vaccine-being-probed-in-us-for-higher-than-expected-risk-of-side-effect\"><strong>Seeking Alpha</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>(Update: August 20, 2021 at 5:59 a.m. ET)\nThe federal health officials are investigating whether the COVID-19 vaccine developed by Moderna, Inc. (NASDAQ: MRNA)is linked to even a higher risk of a rare...</p>\n<a href=\"https://seekingalpha.com/news/3732568-moderna-covid-19-vaccine-being-probed-in-us-for-higher-than-expected-risk-of-side-effect\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3732568-moderna-covid-19-vaccine-being-probed-in-us-for-higher-than-expected-risk-of-side-effect","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189046360","content_text":"(Update: August 20, 2021 at 5:59 a.m. ET)\nThe federal health officials are investigating whether the COVID-19 vaccine developed by Moderna, Inc. (NASDAQ: MRNA)is linked to even a higher risk of a rare side effect called myocarditis in younger adults than initially expected, The WashingtonPost reported citing people familiar with the matter.\nThe people have stressed that the side effect affecting the heart “probably” continues to be uncommon. The probe has involved the officials from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).\nThe investigation is reportedly focused on emerging data from Canada indicating that the vaccine carries a higher risk in the younger population than that from the rival COVID-19 shot from Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), in males below the age of 30 or so in particular.\nThe authorities are trying to establish whether the U.S. data also suggest a higher risk from Moderna’s (MRNA) vaccine in the population.\nIn June, the FDA moved to update the fact sheets of Pfizer (PFE)/ BioNTech (BNTX) and Moderna (MRNA) vaccines to reflect the likelihood of rare cases of heart inflammation following their administration.Moderna sink over 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831620987,"gmtCreate":1629324047249,"gmtModify":1676530000447,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Buy ","listText":"Buy ","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/831620987","repostId":"1122814365","repostType":4,"repost":{"id":"1122814365","kind":"news","pubTimestamp":1629292156,"share":"https://ttm.financial/m/news/1122814365?lang=&edition=full_marsco","pubTime":"2021-08-18 21:09","market":"us","language":"en","title":"4 Hypergrowth Stocks Expected to Increase Sales 1,100% (or More) by 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1122814365","media":"Motley Fool","summary":"Revenue for these fast-paced stocks should skyrocket between 1,100% and 4,200% by mid-decade.\n\nKey P","content":"<html><body><blockquote>\n<b>Revenue for these fast-paced stocks should skyrocket between 1,100% and 4,200% by mid-decade.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n<li>Rapid sales growth doesn't always tell you the full story about a company.</li>\n</ul>\n<p>For the past 12 years, growth stocks have been all the rage on Wall Street -- and with good reason. Historically low lending rates and abundant access to this cheap capital have fueled hiring, innovation, and even acquisitions among fast-paced companies.</p>\n<p>But for some growth stocks, the expected uptick in revenue is just getting started. According to consensus estimates from Wall Street, the following four hypergrowth stocks are expected to increase their sales by anywhere from 1,100% to more than 4,200% over the next three to five years.</p>\n<p><b>Novavax: Implied sales growth of 1,337% by 2025</b></p>\n<p>Biotech stocksare always a good bet to see their sales rocket from zero to hero with their first drug approval. Clinical-stage drug developer<b>Novavax</b>(NASDAQ:NVAX)is expected to do even more with the expected emergency-use authorization (EUA) approval of its coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373. Per Wall Street, Novavax could see sales catapult from nearly $476 million in 2020 to roughly $6.84 billion by 2025.</p>\n<p>To date, Novavax has run two large-scale clinical trials for its COVID-19 vaccine. In March, phase 3 trial data from the U.K. showed a vaccine efficacy (VE) of 89.7%. Data from the second phase 3 study, conducted in the U.S. and Mexico, was released in June and demonstrated a very similar VE of 90.4%. Theeffectiveness of Novavax's vaccinemakes it very likely that it'll soon be authorized in developed markets like the U.S., U.K., and Europe, and could play a key role in emerging markets, as well. Novavax may also push vaccines with lower perceived efficacy --<b>Johnson & Johnson</b> and<b>AstraZeneca</b> -- to the back of the line.</p>\n<p>The only real drag for Novavax shareholders has been the company'snumerous delays in filing for EUA. Initially expected to go after EUA in the U.S. in the second quarter, the company now anticipates filing the appropriate paperwork during the fourth quarter. There have also been concerns about the company's timeline to ramp up vaccine production to full capacity.</p>\n<p>Nevertheless, these delays of a quarter or two aren't going to hamper Novavax's longer-term prospects, which appear to be buoyed by the development of disease variants. The company's ability to quickly develop a vaccine, as well as its early stage research that combines influenza and COVID-19 into a single booster shot, should keep Novavax on the map for a long time to come.</p>\n<p><b>Blink Charging: Implied sales growth of 2,352% by 2025</b></p>\n<p>Another growth stocks with (pun intended) supercharged sales growth potential over the next five years is<b>Blink Charging</b>(NASDAQ:BLNK). Blink provides electric-vehicle (EV) charging infrastructure, as well as owns charging station networks.</p>\n<p>The logic behind Blink's growth is pretty easy to wrap your hands around. Last year, 1.8% of all new vehicles registered in the U.S. were EVs. But by 2025, an IHS Markit study predicts that 10% of all new vehicle registrations will be EVs. As the electrification of America takes shape, demand for charging infrastructureis only going to tick higher. There should be plenty of room for ancillary EV players like Blink Charging to take advantage of this trend for decades to come.</p>\n<p>Based on Wall Street's consensus estimate, Blink Charging is expected to grow its sales from a reported $6.2 million in 2020 to $152 million by mid-decade. That's a 2,352% revenue increase, for those of you keeping score at home.</p>\n<p>However, Blink's future is far from certain. Its current market cap places it at a multiple of 9 times estimated sales for 2025, and it's not particularly close to generating a profit. The company alsodoesn't appear to be investing any of its cash into research and development. With no true means to stand out, it's quite possible Blink Charging gets left in the dust by its competition.</p>\n<p><b>Jushi Holdings: Implied sales growth of 1,101% by 2024</b></p>\n<p>U.S.marijuana stocks are a fantastic bet to deliver triple-digit aggregate sales growth over the next three to five years as new states legalize pot and already legalized states benefit from organic growth. But you can forget about triple-digit sales growth with multistate operator<b>Jushi Holdings</b>(OTC:JUSHF). According to estimates from <b>FactSet</b>, Jushi's projected push to $969 million in annual revenue by 2024 would mark a 1,101% increase from the $80.7 million in sales generated last year.</p>\n<p>Operating in the highly lucrative U.S. market is bound to give Jushi a boost. We've already seen 36 states legalize cannabis in some capacity, 18 of which have passed legislation to allow for the consumption and/or retail sale of adult-use weed. If New Frontier Data's latest report on the U.S. pot industry proves accurate, legal weed sales could grow by an annualized average of 21% through 2025, ultimately hitting north of $41 billion.</p>\n<p>Jushi is a relatively small player in the cannabis space, for the time being. It has 20 operating dispensaries, but will likely end the year closer to 30, inclusive of organic openings and acquisitions. The company's core focus is on a trio of limited-license states: Virginia, Pennsylvania, and Illinois. The former issues licenses based on jurisdiction, whereas the latter two limit the aggregate number of retail and cultivation licenses assigned. By targeting limited-license states, Jushi will be somewhat protected from competitors with deeper pockets.</p>\n<p>Similar to Novavax, Jushi is expected to turn the corner to recurring profitability in 2022. It looks to be one of the biggest bargains in the cannabis industry.</p>\n<p><b>Riot Blockchain: Implied sales growth of 4,231% by 2023</b></p>\n<p>The last hypergrowth stock expected to deliver insane revenue growth in the coming years is cryptocurrency miningcompany<b>Riot Blockchain</b>(NASDAQ:RIOT). After reporting just $12.1 million in full-year sales in 2020, Wall Street is expecting Riot to bring in $524 million in revenue by 2023. That's a greater than 4,200% sales increase in just three years.</p>\n<p>Cryptocurrency miners are people or companies that use high-powered computers to solve complex mathematical equations to validate groups of transactions known as a block. For doing so, crypto miners are paid a block reward. In Riot's case, its revenue is soaring becauseit's building up its farmto mine <b>Bitcoin</b>(CRYPTO:BTC), the world's largest digital currency by market cap. The Bitcoin block reward equates to 6.25 Bitcoin, which is worth about $287,000, as of August 15.</p>\n<p>As of the end of July, Riot Blockchain held approximately 2,687 Bitcoin on its balance sheet (these are tokens the company has mined since inception), with plans to have 25,946 Antminers in operation by early September. The goal for Riot Blockchain is to have its full fleet of miners (81,146 Antminers) in operation by the fourth quarter of 2022.</p>\n<p>While the sales growth in Bitcoin mining stocks is undeniable, therisks are hard to overlook, as well. Instead of being reliant on innovation, Riot is entirely dependent on investor sentiment in Bitcoin and the price of the token. We've also witnessed three declines of at least 80% in Bitcoin over the past decade, which could potentially crush Riot Blockchain's operating model.</p>\n<p>But the real concern is that there's no barrier to entry in the crypto mining space, and Bitcoin block rewards will halve to 3.125 tokens by 2024. This is a highly competitive space with decreasing rewards.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>4 Hypergrowth Stocks Expected to Increase Sales 1,100% (or More) by 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Hypergrowth Stocks Expected to Increase Sales 1,100% (or More) by 2025\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-18 21:09 GMT+8 <a href=\"https://www.fool.com/investing/2021/08/18/4-hypergrowth-stocks-increase-sales-1100-by-2025/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Revenue for these fast-paced stocks should skyrocket between 1,100% and 4,200% by mid-decade.\n\nKey Points\n\nRapid sales growth doesn't always tell you the full story about a company.\n\nFor the past 12 ...</p>\n<a href=\"https://www.fool.com/investing/2021/08/18/4-hypergrowth-stocks-increase-sales-1100-by-2025/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BLNK":"Blink Charging","RIOT":"Riot Platforms"},"source_url":"https://www.fool.com/investing/2021/08/18/4-hypergrowth-stocks-increase-sales-1100-by-2025/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122814365","content_text":"Revenue for these fast-paced stocks should skyrocket between 1,100% and 4,200% by mid-decade.\n\nKey Points\n\nRapid sales growth doesn't always tell you the full story about a company.\n\nFor the past 12 years, growth stocks have been all the rage on Wall Street -- and with good reason. Historically low lending rates and abundant access to this cheap capital have fueled hiring, innovation, and even acquisitions among fast-paced companies.\nBut for some growth stocks, the expected uptick in revenue is just getting started. According to consensus estimates from Wall Street, the following four hypergrowth stocks are expected to increase their sales by anywhere from 1,100% to more than 4,200% over the next three to five years.\nNovavax: Implied sales growth of 1,337% by 2025\nBiotech stocksare always a good bet to see their sales rocket from zero to hero with their first drug approval. Clinical-stage drug developerNovavax(NASDAQ:NVAX)is expected to do even more with the expected emergency-use authorization (EUA) approval of its coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373. Per Wall Street, Novavax could see sales catapult from nearly $476 million in 2020 to roughly $6.84 billion by 2025.\nTo date, Novavax has run two large-scale clinical trials for its COVID-19 vaccine. In March, phase 3 trial data from the U.K. showed a vaccine efficacy (VE) of 89.7%. Data from the second phase 3 study, conducted in the U.S. and Mexico, was released in June and demonstrated a very similar VE of 90.4%. Theeffectiveness of Novavax's vaccinemakes it very likely that it'll soon be authorized in developed markets like the U.S., U.K., and Europe, and could play a key role in emerging markets, as well. Novavax may also push vaccines with lower perceived efficacy --Johnson & Johnson andAstraZeneca -- to the back of the line.\nThe only real drag for Novavax shareholders has been the company'snumerous delays in filing for EUA. Initially expected to go after EUA in the U.S. in the second quarter, the company now anticipates filing the appropriate paperwork during the fourth quarter. There have also been concerns about the company's timeline to ramp up vaccine production to full capacity.\nNevertheless, these delays of a quarter or two aren't going to hamper Novavax's longer-term prospects, which appear to be buoyed by the development of disease variants. The company's ability to quickly develop a vaccine, as well as its early stage research that combines influenza and COVID-19 into a single booster shot, should keep Novavax on the map for a long time to come.\nBlink Charging: Implied sales growth of 2,352% by 2025\nAnother growth stocks with (pun intended) supercharged sales growth potential over the next five years isBlink Charging(NASDAQ:BLNK). Blink provides electric-vehicle (EV) charging infrastructure, as well as owns charging station networks.\nThe logic behind Blink's growth is pretty easy to wrap your hands around. Last year, 1.8% of all new vehicles registered in the U.S. were EVs. But by 2025, an IHS Markit study predicts that 10% of all new vehicle registrations will be EVs. As the electrification of America takes shape, demand for charging infrastructureis only going to tick higher. There should be plenty of room for ancillary EV players like Blink Charging to take advantage of this trend for decades to come.\nBased on Wall Street's consensus estimate, Blink Charging is expected to grow its sales from a reported $6.2 million in 2020 to $152 million by mid-decade. That's a 2,352% revenue increase, for those of you keeping score at home.\nHowever, Blink's future is far from certain. Its current market cap places it at a multiple of 9 times estimated sales for 2025, and it's not particularly close to generating a profit. The company alsodoesn't appear to be investing any of its cash into research and development. With no true means to stand out, it's quite possible Blink Charging gets left in the dust by its competition.\nJushi Holdings: Implied sales growth of 1,101% by 2024\nU.S.marijuana stocks are a fantastic bet to deliver triple-digit aggregate sales growth over the next three to five years as new states legalize pot and already legalized states benefit from organic growth. But you can forget about triple-digit sales growth with multistate operatorJushi Holdings(OTC:JUSHF). According to estimates from FactSet, Jushi's projected push to $969 million in annual revenue by 2024 would mark a 1,101% increase from the $80.7 million in sales generated last year.\nOperating in the highly lucrative U.S. market is bound to give Jushi a boost. We've already seen 36 states legalize cannabis in some capacity, 18 of which have passed legislation to allow for the consumption and/or retail sale of adult-use weed. If New Frontier Data's latest report on the U.S. pot industry proves accurate, legal weed sales could grow by an annualized average of 21% through 2025, ultimately hitting north of $41 billion.\nJushi is a relatively small player in the cannabis space, for the time being. It has 20 operating dispensaries, but will likely end the year closer to 30, inclusive of organic openings and acquisitions. The company's core focus is on a trio of limited-license states: Virginia, Pennsylvania, and Illinois. The former issues licenses based on jurisdiction, whereas the latter two limit the aggregate number of retail and cultivation licenses assigned. By targeting limited-license states, Jushi will be somewhat protected from competitors with deeper pockets.\nSimilar to Novavax, Jushi is expected to turn the corner to recurring profitability in 2022. It looks to be one of the biggest bargains in the cannabis industry.\nRiot Blockchain: Implied sales growth of 4,231% by 2023\nThe last hypergrowth stock expected to deliver insane revenue growth in the coming years is cryptocurrency miningcompanyRiot Blockchain(NASDAQ:RIOT). After reporting just $12.1 million in full-year sales in 2020, Wall Street is expecting Riot to bring in $524 million in revenue by 2023. That's a greater than 4,200% sales increase in just three years.\nCryptocurrency miners are people or companies that use high-powered computers to solve complex mathematical equations to validate groups of transactions known as a block. For doing so, crypto miners are paid a block reward. In Riot's case, its revenue is soaring becauseit's building up its farmto mine Bitcoin(CRYPTO:BTC), the world's largest digital currency by market cap. The Bitcoin block reward equates to 6.25 Bitcoin, which is worth about $287,000, as of August 15.\nAs of the end of July, Riot Blockchain held approximately 2,687 Bitcoin on its balance sheet (these are tokens the company has mined since inception), with plans to have 25,946 Antminers in operation by early September. The goal for Riot Blockchain is to have its full fleet of miners (81,146 Antminers) in operation by the fourth quarter of 2022.\nWhile the sales growth in Bitcoin mining stocks is undeniable, therisks are hard to overlook, as well. Instead of being reliant on innovation, Riot is entirely dependent on investor sentiment in Bitcoin and the price of the token. We've also witnessed three declines of at least 80% in Bitcoin over the past decade, which could potentially crush Riot Blockchain's operating model.\nBut the real concern is that there's no barrier to entry in the crypto mining space, and Bitcoin block rewards will halve to 3.125 tokens by 2024. This is a highly competitive space with decreasing rewards.","news_type":1},"isVote":1,"tweetType":1,"viewCount":573,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9993049644,"gmtCreate":1660609376590,"gmtModify":1676536363679,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9993049644","repostId":"2259122027","repostType":4,"repost":{"id":"2259122027","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1660604534,"share":"https://ttm.financial/m/news/2259122027?lang=&edition=full_marsco","pubTime":"2022-08-16 07:02","market":"us","language":"en","title":"US STOCKS-Wall Street Climbs, Adding to Recent Gains As Megacaps Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2259122027","media":"Reuters","summary":"(Reuters) - U.S. stocks rose on Monday with megacap growth shares, extending the market's recent ral","content":"<html><head></head><body><p>(Reuters) - U.S. stocks rose on Monday with megacap growth shares, extending the market's recent rally amid investor optimism the Federal Reserve can achieve a soft landing for the economy.</p><p>Shares of Apple Inc climbed 0.6%, while Microsoft Corp rose 0.5% and Tesla Inc jumped 3.1%.</p><p>Those stocks gave the S&P 500 and Nasdaq their biggest boosts as U.S. Treasury yields eased. China's central bank cut key lending rates in a surprise move to revive demand after the economy unexpectedly slowed in July.</p><p>Consumer staples and utilities sectors also had strong gains.</p><p>The S&P 500 has rebounded sharply since mid-June, helped last week by signs that inflation may have peaked in July. The benchmark remains down about 10% since Dec. 31.</p><p>\"Market participants (are) looking at the Fed and saying, 'Hey, they're going to be cutting rates here sooner than we know, and that's going to be good for the equity market,'\" said Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago.</p><p>The Dow Jones Industrial Average rose 151.39 points, or 0.45%, to 33,912.44, the S&P 500 gained 16.99 points, or 0.40%, to 4,297.14 and the Nasdaq Composite added 80.87 points, or 0.62%, to 13,128.05.</p><p>The Fed since March has delivered a stiff set of interest rate increases in an effort to battle inflation. Some investors have worried that an aggressive pace of rate hikes by the U.S. central bank could push the economy into recession.</p><p>Higher interest rates can depress stock multiples, especially of technology and other growth stocks.</p><p>The S&P 500 value index underperformed the S&P 500 growth index on the day. The S&P 500 energy index was down 2%.</p><p>Quarterly reports from big retailers are expected this week and will round out the second-quarter reporting period. Results from Walmart Inc and Home Depot Inc are due before the bell on Tuesday. Walmart was up 0.3% while Home Depot was nearly flat.</p><p>Target Corp is also due to report quarterly results this week.</p><p>Estimated earnings growth on the second quarter for S&P 500 companies has improved since July 1, and news from U.S. companies has mostly surprised investors, who had been bracing for a gloomier outlook on both businesses and the economy.</p><p>U.S.-listed shares of China's e-commerce giant Alibaba Group Holding Ltd slipped 0.6%.</p><p>Volume on U.S. exchanges was among the lowest so far this year. About 9.59 billion shares changed hands, compared with the 10.97 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.09-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored advancers.</p><p>The S&P 500 posted 9 new 52-week highs and 29 new lows; the Nasdaq Composite recorded 82 new highs and 27 new lows.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>US STOCKS-Wall Street Climbs, Adding to Recent Gains As Megacaps Rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street Climbs, Adding to Recent Gains As Megacaps Rise\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-08-16 07:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(Reuters) - U.S. stocks rose on Monday with megacap growth shares, extending the market's recent rally amid investor optimism the Federal Reserve can achieve a soft landing for the economy.</p><p>Shares of Apple Inc climbed 0.6%, while Microsoft Corp rose 0.5% and Tesla Inc jumped 3.1%.</p><p>Those stocks gave the S&P 500 and Nasdaq their biggest boosts as U.S. Treasury yields eased. China's central bank cut key lending rates in a surprise move to revive demand after the economy unexpectedly slowed in July.</p><p>Consumer staples and utilities sectors also had strong gains.</p><p>The S&P 500 has rebounded sharply since mid-June, helped last week by signs that inflation may have peaked in July. The benchmark remains down about 10% since Dec. 31.</p><p>\"Market participants (are) looking at the Fed and saying, 'Hey, they're going to be cutting rates here sooner than we know, and that's going to be good for the equity market,'\" said Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago.</p><p>The Dow Jones Industrial Average rose 151.39 points, or 0.45%, to 33,912.44, the S&P 500 gained 16.99 points, or 0.40%, to 4,297.14 and the Nasdaq Composite added 80.87 points, or 0.62%, to 13,128.05.</p><p>The Fed since March has delivered a stiff set of interest rate increases in an effort to battle inflation. Some investors have worried that an aggressive pace of rate hikes by the U.S. central bank could push the economy into recession.</p><p>Higher interest rates can depress stock multiples, especially of technology and other growth stocks.</p><p>The S&P 500 value index underperformed the S&P 500 growth index on the day. The S&P 500 energy index was down 2%.</p><p>Quarterly reports from big retailers are expected this week and will round out the second-quarter reporting period. Results from Walmart Inc and Home Depot Inc are due before the bell on Tuesday. Walmart was up 0.3% while Home Depot was nearly flat.</p><p>Target Corp is also due to report quarterly results this week.</p><p>Estimated earnings growth on the second quarter for S&P 500 companies has improved since July 1, and news from U.S. companies has mostly surprised investors, who had been bracing for a gloomier outlook on both businesses and the economy.</p><p>U.S.-listed shares of China's e-commerce giant Alibaba Group Holding Ltd slipped 0.6%.</p><p>Volume on U.S. exchanges was among the lowest so far this year. About 9.59 billion shares changed hands, compared with the 10.97 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.09-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored advancers.</p><p>The S&P 500 posted 9 new 52-week highs and 29 new lows; the Nasdaq Composite recorded 82 new highs and 27 new lows.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2259122027","content_text":"(Reuters) - U.S. stocks rose on Monday with megacap growth shares, extending the market's recent rally amid investor optimism the Federal Reserve can achieve a soft landing for the economy.Shares of Apple Inc climbed 0.6%, while Microsoft Corp rose 0.5% and Tesla Inc jumped 3.1%.Those stocks gave the S&P 500 and Nasdaq their biggest boosts as U.S. Treasury yields eased. China's central bank cut key lending rates in a surprise move to revive demand after the economy unexpectedly slowed in July.Consumer staples and utilities sectors also had strong gains.The S&P 500 has rebounded sharply since mid-June, helped last week by signs that inflation may have peaked in July. The benchmark remains down about 10% since Dec. 31.\"Market participants (are) looking at the Fed and saying, 'Hey, they're going to be cutting rates here sooner than we know, and that's going to be good for the equity market,'\" said Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago.The Dow Jones Industrial Average rose 151.39 points, or 0.45%, to 33,912.44, the S&P 500 gained 16.99 points, or 0.40%, to 4,297.14 and the Nasdaq Composite added 80.87 points, or 0.62%, to 13,128.05.The Fed since March has delivered a stiff set of interest rate increases in an effort to battle inflation. Some investors have worried that an aggressive pace of rate hikes by the U.S. central bank could push the economy into recession.Higher interest rates can depress stock multiples, especially of technology and other growth stocks.The S&P 500 value index underperformed the S&P 500 growth index on the day. The S&P 500 energy index was down 2%.Quarterly reports from big retailers are expected this week and will round out the second-quarter reporting period. Results from Walmart Inc and Home Depot Inc are due before the bell on Tuesday. Walmart was up 0.3% while Home Depot was nearly flat.Target Corp is also due to report quarterly results this week.Estimated earnings growth on the second quarter for S&P 500 companies has improved since July 1, and news from U.S. companies has mostly surprised investors, who had been bracing for a gloomier outlook on both businesses and the economy.U.S.-listed shares of China's e-commerce giant Alibaba Group Holding Ltd slipped 0.6%.Volume on U.S. exchanges was among the lowest so far this year. About 9.59 billion shares changed hands, compared with the 10.97 billion average for the full session over the last 20 trading days.Advancing issues outnumbered declining ones on the NYSE by a 1.09-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored advancers.The S&P 500 posted 9 new 52-week highs and 29 new lows; the Nasdaq Composite recorded 82 new highs and 27 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1088,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179036872,"gmtCreate":1626471029796,"gmtModify":1703760648907,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/179036872","repostId":"1149577900","repostType":4,"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148185897,"gmtCreate":1625960620519,"gmtModify":1703751148239,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/148185897","repostId":"2150370120","repostType":4,"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168165205,"gmtCreate":1623966649407,"gmtModify":1703824714856,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/168165205","repostId":"2144742672","repostType":4,"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573639758582771","authorId":"3573639758582771","name":"pal22","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3573639758582771","authorIdStr":"3573639758582771"},"content":"like and comment","text":"like and comment","html":"like and comment"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804348585,"gmtCreate":1627940980147,"gmtModify":1703498084471,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Yes ","listText":"Yes ","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804348585","repostId":"1172320411","repostType":4,"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173695367,"gmtCreate":1626656354959,"gmtModify":1703762739534,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/173695367","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805928914,"gmtCreate":1627854439638,"gmtModify":1703496461571,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805928914","repostId":"2155001152","repostType":4,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800321657,"gmtCreate":1627279877079,"gmtModify":1703486620461,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800321657","repostId":"1100772026","repostType":4,"isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155717070,"gmtCreate":1625453511490,"gmtModify":1703742008126,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/155717070","repostId":"1170100655","repostType":4,"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9046088881,"gmtCreate":1656284550043,"gmtModify":1676535796618,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046088881","repostId":"1184080362","repostType":2,"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127341306,"gmtCreate":1624837472105,"gmtModify":1703845680308,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/127341306","repostId":"1104974895","repostType":4,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803364099,"gmtCreate":1627422608912,"gmtModify":1703489476518,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/803364099","repostId":"1108849761","repostType":4,"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178614651,"gmtCreate":1626816636173,"gmtModify":1703765598713,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/178614651","repostId":"1127649148","repostType":4,"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178615976,"gmtCreate":1626816411695,"gmtModify":1703765596443,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Buy ","listText":"Buy ","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/178615976","repostId":"2152657163","repostType":4,"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360674084,"gmtCreate":1613915460648,"gmtModify":1704885901324,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/360674084","repostId":"1143100356","repostType":4,"isVote":1,"tweetType":1,"viewCount":187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9980010210,"gmtCreate":1665616729331,"gmtModify":1676537635029,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9980010210","repostId":"2275695842","repostType":4,"repost":{"id":"2275695842","kind":"highlight","pubTimestamp":1665615903,"share":"https://ttm.financial/m/news/2275695842?lang=&edition=full_marsco","pubTime":"2022-10-13 07:05","market":"us","language":"en","title":"Amazon to Shut Down \"Explore\" Virtual Tour Product in Latest Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2275695842","media":"Bloomberg","summary":"Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched ","content":"<html><head></head><body><p>Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched during the pandemic, in the latest belt-tightening move by the online giant as it adjusts to slowing sales.</p><p>“At Amazon, we are always experimenting and testing ideas like Amazon Explore,” the company said Wednesday in a statement. “While we are winding down this program, we’ll continue innovating and investing in new ways to delight our customers. We are supporting our affected employees during this transition and working to identify other opportunities within Amazon.”</p><p>Amazon launched Explore in 2020, targeting those suffering cabin fever during pandemic lockdowns. Users could pay $7.50 for a 50-minute guided tour of sites such as an animal sanctuary in Costa Rica or $50 for an hourlong virtual stroll through the markets of Venice.</p><p>Amazon has been trimming experimental programs to reduce costs. Among the features or products that have been curtailed or canceled are Scout, an autonomous delivery robot and Amazon Glow, a kids-focused video calling device. The company has also frozen hiring for its corporate retail teams and is winding down Amazon Care, its startup telehealth service.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Amazon to Shut Down \"Explore\" Virtual Tour Product in Latest Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon to Shut Down \"Explore\" Virtual Tour Product in Latest Cut\n</h2>\n<h4 class=\"meta\">\n\n\n2022-10-13 07:05 GMT+8 <a href=\"https://www.bloomberg.com/news/articles/2022-10-12/amazon-to-shutter-virtual-tour-product-explore-in-latest-cut?srnd=technology-vp\"><strong>Bloomberg</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched during the pandemic, in the latest belt-tightening move by the online giant as it adjusts to slowing...</p>\n<a href=\"https://www.bloomberg.com/news/articles/2022-10-12/amazon-to-shutter-virtual-tour-product-explore-in-latest-cut?srnd=technology-vp\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.bloomberg.com/news/articles/2022-10-12/amazon-to-shutter-virtual-tour-product-explore-in-latest-cut?srnd=technology-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2275695842","content_text":"Amazon.com Inc. is shutting down a virtual tour feature called “Amazon Explore,” which was launched during the pandemic, in the latest belt-tightening move by the online giant as it adjusts to slowing sales.“At Amazon, we are always experimenting and testing ideas like Amazon Explore,” the company said Wednesday in a statement. “While we are winding down this program, we’ll continue innovating and investing in new ways to delight our customers. We are supporting our affected employees during this transition and working to identify other opportunities within Amazon.”Amazon launched Explore in 2020, targeting those suffering cabin fever during pandemic lockdowns. Users could pay $7.50 for a 50-minute guided tour of sites such as an animal sanctuary in Costa Rica or $50 for an hourlong virtual stroll through the markets of Venice.Amazon has been trimming experimental programs to reduce costs. Among the features or products that have been curtailed or canceled are Scout, an autonomous delivery robot and Amazon Glow, a kids-focused video calling device. The company has also frozen hiring for its corporate retail teams and is winding down Amazon Care, its startup telehealth service.","news_type":1},"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863702579,"gmtCreate":1632432374591,"gmtModify":1676530779311,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":" Good ","listText":" Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863702579","repostId":"2169695648","repostType":2,"repost":{"id":"2169695648","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1632428141,"share":"https://ttm.financial/m/news/2169695648?lang=&edition=full_marsco","pubTime":"2021-09-24 04:15","market":"us","language":"en","title":"Nike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2169695648","media":"Benzinga","summary":"Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period","content":"<html><body><p>Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $12.20 billion which missed the analyst consensus estimate of $12.46 billion by 2.09 percent. This is a 15.16 percent increase over sales of $10.59 billion the same period last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Nike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike Q1 EPS $1.16 Beats $1.11 Estimate, Sales $12.20B Miss $12.46B Estimate\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-24 04:15</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $12.20 billion which missed the analyst consensus estimate of $12.46 billion by 2.09 percent. This is a 15.16 percent increase over sales of $10.59 billion the same period last year.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克"},"source_url":"https://www.benzinga.com/news/earnings/21/09/23080496/nike-q1-eps-1-16-beats-1-11-estimate-sales-12-20b-miss-12-46b-estimate","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169695648","content_text":"Nike (NYSE:NKE) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.11 by 4.5 percent. This is a 22.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $12.20 billion which missed the analyst consensus estimate of $12.46 billion by 2.09 percent. This is a 15.16 percent increase over sales of $10.59 billion the same period last year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":686,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884549153,"gmtCreate":1631922304672,"gmtModify":1676530668704,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884549153","repostId":"2168552491","repostType":4,"repost":{"id":"2168552491","kind":"highlight","pubTimestamp":1631878843,"share":"https://ttm.financial/m/news/2168552491?lang=&edition=full_marsco","pubTime":"2021-09-17 19:40","market":"us","language":"en","title":"3 Top Warren Buffett Stocks to Buy and Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2168552491","media":"Motley Fool","summary":"Invest like the legendary multibillionaire with these three great stocks.","content":"<html><body><p>Follow the leader. It's not just a game that children play. For some, it's their investment strategy.</p>\n<p>The idea is to base your own investments on a successful investor's portfolio. There are quite a few famous investors who you could follow, and Warren Buffett stands out as one of the greatest. He earned the nickname \"Oracle of Omaha\" by outperforming the market for decades.</p>\n<p>Following the leader isn't always the best investing approach, though. Your current situation and goals are likely quite different from a multibillionaire like Buffett.</p>\n<p>However, there are some stocks that the legendary investor likes that are also great long-term picks for many not-so-famous investors. Here are three top Buffett stocks to buy and hold.</p>\n<p class=\"t-img-caption\"><img height=\"auto\" src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642023%2Fwarren-buffett-tmf.jpg&w=700&op=resize\" tg-height=\"466\" tg-width=\"700\" width=\"100%\"/><span>Image source: The Motley Fool.</span></p>\n<h2>1. Berkshire Hathaway</h2>\n<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) stands out as the obvious Buffett stock to buy and hold. With Berkshire, you'll get to fully share in the great investor's future success.</p>\n<p>From 1965 (when Buffett took over) to 2020, Berkshire Hathaway stock delivered a compounded annual gain of 20%. That's nearly double the return of the <b>S&P 500 index </b>during the period. So far this year, Berkshire's performance is close to its historical average gain.</p>\n<p>Will Berkshire keep up its winning ways? Probably so. For one thing, the company sits atop a massive cash stockpile of more than $140 billion. And Berkshire's core businesses keep churning out more cash. There's a lot of dry powder to use in buying stocks at a discount in the next major pullback.</p>\n<p>Also, Buffett is allowing his investment managers to call the shots more frequently on which stocks to buy. That's resulting in a more aggressive strategy that could pay off handsomely over the long term.</p>\n<h2>2. Apple</h2>\n<p>Outside of Berkshire Hathaway itself, <b>Apple</b> (NASDAQ:AAPL) ranks as Buffett's favorite stock. It's no coincidence that Berkshire owns far more shares of the tech giant than any other company.</p>\n<p>Apple stock has given investors more than a five times return over the last five years, but shares are lagging behind the overall market in 2021. However, this $2.5 trillion company still has plenty of room to grow.</p>\n<p>The increased adoption of 5G networks continues to fuel higher iPhone sales. This trend also benefits much of Apple's ecosystem, including the App Store, iCloud, and peripheral devices such as AirPods and Apple Watch.</p>\n<p>Apple also has other growth drivers. Its AppleTV+ streaming service is becoming a powerhouse in its own right. Augmented reality and virtual reality also present tremendous growth opportunities for the company.</p>\n<h2>3. Johnson & Johnson</h2>\n<p>Buffett used to be a bigger fan of <b>Johnson & Johnson</b> (NYSE:JNJ) than he is now. The healthcare stock makes up only a tiny portion of Berkshire's portfolio. However, J&J is nonetheless one of the best Buffett stocks to own if you have a long-term investing horizon.</p>\n<p>Johnson & Johnson is the biggest global player in the fast-growing healthcare market. Many of its products are necessities instead of \"nice-to-haves.\" J&J is a leader in multiple major healthcare arenas -- consumer health, medical devices, and pharmaceuticals.</p>\n<p>Granted, Johnson & Johnson stock has badly underperformed the <b>S&P 500</b> over the last decade. The company is in a stronger position for growth now, though, thanks in large part to its research and development investments and acquisitions. Roughly one-fourth of J&J's total sales come from products launched over the past five years.</p>\n<p>Buffett lives by two rules of investing. Rule No. 1 is never lose money. Rule No. 2 is don't forget Rule No. 1. With its diversified healthcare operations and financial strength, Johnson & Johnson is arguably one of the best stocks to buy and hold to follow Buffett's investing rules.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>3 Top Warren Buffett Stocks to Buy and Hold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Warren Buffett Stocks to Buy and Hold\n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-17 19:40 GMT+8 <a href=\"https://www.fool.com/investing/2021/09/17/3-top-warren-buffett-stocks-to-buy-and-hold/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Follow the leader. It's not just a game that children play. For some, it's their investment strategy.\nThe idea is to base your own investments on a successful investor's portfolio. There are quite a ...</p>\n<a href=\"https://www.fool.com/investing/2021/09/17/3-top-warren-buffett-stocks-to-buy-and-hold/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","JNJ":"强生","AAPL":"苹果","BRK.B":"伯克希尔B"},"source_url":"https://www.fool.com/investing/2021/09/17/3-top-warren-buffett-stocks-to-buy-and-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168552491","content_text":"Follow the leader. It's not just a game that children play. For some, it's their investment strategy.\nThe idea is to base your own investments on a successful investor's portfolio. There are quite a few famous investors who you could follow, and Warren Buffett stands out as one of the greatest. He earned the nickname \"Oracle of Omaha\" by outperforming the market for decades.\nFollowing the leader isn't always the best investing approach, though. Your current situation and goals are likely quite different from a multibillionaire like Buffett.\nHowever, there are some stocks that the legendary investor likes that are also great long-term picks for many not-so-famous investors. Here are three top Buffett stocks to buy and hold.\nImage source: The Motley Fool.\n1. Berkshire Hathaway\nBerkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) stands out as the obvious Buffett stock to buy and hold. With Berkshire, you'll get to fully share in the great investor's future success.\nFrom 1965 (when Buffett took over) to 2020, Berkshire Hathaway stock delivered a compounded annual gain of 20%. That's nearly double the return of the S&P 500 index during the period. So far this year, Berkshire's performance is close to its historical average gain.\nWill Berkshire keep up its winning ways? Probably so. For one thing, the company sits atop a massive cash stockpile of more than $140 billion. And Berkshire's core businesses keep churning out more cash. There's a lot of dry powder to use in buying stocks at a discount in the next major pullback.\nAlso, Buffett is allowing his investment managers to call the shots more frequently on which stocks to buy. That's resulting in a more aggressive strategy that could pay off handsomely over the long term.\n2. Apple\nOutside of Berkshire Hathaway itself, Apple (NASDAQ:AAPL) ranks as Buffett's favorite stock. It's no coincidence that Berkshire owns far more shares of the tech giant than any other company.\nApple stock has given investors more than a five times return over the last five years, but shares are lagging behind the overall market in 2021. However, this $2.5 trillion company still has plenty of room to grow.\nThe increased adoption of 5G networks continues to fuel higher iPhone sales. This trend also benefits much of Apple's ecosystem, including the App Store, iCloud, and peripheral devices such as AirPods and Apple Watch.\nApple also has other growth drivers. Its AppleTV+ streaming service is becoming a powerhouse in its own right. Augmented reality and virtual reality also present tremendous growth opportunities for the company.\n3. Johnson & Johnson\nBuffett used to be a bigger fan of Johnson & Johnson (NYSE:JNJ) than he is now. The healthcare stock makes up only a tiny portion of Berkshire's portfolio. However, J&J is nonetheless one of the best Buffett stocks to own if you have a long-term investing horizon.\nJohnson & Johnson is the biggest global player in the fast-growing healthcare market. Many of its products are necessities instead of \"nice-to-haves.\" J&J is a leader in multiple major healthcare arenas -- consumer health, medical devices, and pharmaceuticals.\nGranted, Johnson & Johnson stock has badly underperformed the S&P 500 over the last decade. The company is in a stronger position for growth now, though, thanks in large part to its research and development investments and acquisitions. Roughly one-fourth of J&J's total sales come from products launched over the past five years.\nBuffett lives by two rules of investing. Rule No. 1 is never lose money. Rule No. 2 is don't forget Rule No. 1. With its diversified healthcare operations and financial strength, Johnson & Johnson is arguably one of the best stocks to buy and hold to follow Buffett's investing rules.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}